Decoding the Epigenetics and Chromatin Loop Dynamics of Androgen Receptor-Mediated Transcription | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article Decoding the Epigenetics and Chromatin Loop Dynamics of Androgen Receptor-Mediated Transcription Nathan Lack, Umut Berkay Altintas, Ji-Heu Seo, Claudia Giambartolomei, and 7 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-3854707/v1 This work is licensed under a CC BY 4.0 License Status: Published Journal Publication published 03 Nov, 2024 Read the published version in Nature Communications → Version 1 posted You are reading this latest preprint version Abstract Androgen receptor (AR)-mediated transcription plays a critical role in normal prostate development and prostate cancer growth. AR drives gene expression by binding to thousands of cis-regulatory elements (CRE) that loop to hundreds of target promoters. With multiple CREs interacting with a single promoter, it remains unclear how individual AR bound CREs contribute to gene expression. To characterize the involvement of these CREs, we investigated the AR-driven epigenetic and chromosomal chromatin looping changes. We collected a kinetic multi-omic dataset comprised of steady-state mRNA, chromatin accessibility, transcription factor binding, histone modifications, chromatin looping, and nascent RNA. Using an integrated regulatory network, we found that AR binding induces sequential changes in the epigenetic features at CREs, independent of gene expression. Further, we showed that binding of AR does not result in a substantial rewiring of chromatin loops, but instead increases the contact frequency of pre-existing loops to target promoters. Our results show that gene expression strongly correlates to the changes in contact frequency. We then proposed and experimentally validated an unbalanced multi-enhancer model where the impact on gene expression of AR-bound enhancers is heterogeneous, and is proportional to their contact frequency with target gene promoters. Overall, these findings provide new insight into AR-mediated gene expression upon acute androgen simulation and develop a mechanistic framework to investigate nuclear receptor mediated perturbations. Biological sciences/Molecular biology/Transcription/Transcriptional regulatory elements Biological sciences/Molecular biology/Chromatin/Chromatin structure Biological sciences/Computational biology and bioinformatics/Databases Biological sciences/Genetics/Epigenomics Androgen receptor (AR) Transcription factor (TF) Cis-regulatory elements (CRE) 3D Genome organization Gene expression regulation Figures Figure 1 Figure 2 Figure 3 Figure 4 Figure 5 Figure 6 INTRODUCTION The androgen receptor (AR) is a ligand-dependent transcription factor that plays a critical role in regulating gene expression in the prostate 1 . In its inactive form, the AR resides in the cytoplasm where it is stabilized by heat-shock chaperone proteins 2 . After binding androgens, such as testosterone or dihydrotestosterone (DHT), the AR undergoes an allosteric modification and translocates into the nucleus 2–4 . Once there, the AR binds to specific cis-regulatory elements (CREs) on DNA through an interplay of chromatin accessibility, pioneer factors such as FOXA1, and sequence motifs 5–9 . The majority of these AR-bound CREs are proposed to function as enhancers as they are located distal from gene promoters 10 and are brought into close physical proximity by chromatin loops 11,12 . The enhancer activity at these CREs is associated with various epigenetic features, including chromatin accessibility, transcription factor binding, and post-translational histone modifications, such as H3K27ac and H3K4me3 13–19 . CREs are proposed to impact transcription through chromatin contacts with the target promoter that cause the recruitment of co-regulatory proteins and transcriptional machinery 20–23 . This typically involves multiple AR-bound enhancers and CREs that interact with the target promoter 24–30 . The contribution of individual CREs has been controversial with some studies suggesting that CREs work additively to increase gene expression 31–33 , while others propose that many enhancers are redundant and only contribute at specific developmental stages 34–37 . The complex kinetic interplay of epigenetic modifications, co-regulatory proteins and chromatin loops across multiple CREs following transcription factor binding is poorly understood. To explore how AR binding impacts epigenetic modifications and chromatin looping at regulatory elements in response to an acute perturbation, we generated an extensive multi-omics experimental dataset following androgen stimulation that was integrated into a graph-based framework. We demonstrated that AR binding sequentially induces an increase in FOXA1 and H3K27ac signals, that was followed by an increase in chromatin accessibility. We further show that AR does not induce new chromatin loops, but instead increases the contact frequency between gene promoters and selective AR-bound enhancers. From these results, we generated and validated a multi-enhancer model, where a small subset of pre-established dominant CREs with increased chromatin contact frequency exhibits an elevated dynamic response to androgen stimulation, which significantly contribute to gene expression. These results provide a foundation for understanding how enhancers respond to an acute perturbation. METHODS Experimental LNCaP Cell culture and DHT treatment LNCaP cells (#CRL-1740, ATCC) were grown in phenol red-free RPMI (#11835030, GIBCO) with 10% charcoal-stripped FBS (#100–119, GemBio) for 3 days and then were stimulated with 10nM dihydrotestosterone (DHT) (A8380, Sigma) for 0.5, 4, 16 or 72 hours. For the vehicle samples, the cells were treated with 100% EtOH. Subsequently, cells were collected for further experiments (ChIP-seq, RNA-seq, ATAC-seq, HiChIP, or Start-seq) accordingly 38 . LNCaP cells were authenticated by sequencing and comparing short tandem repeats to parental LNCaP cells in the ATCC database. Prior to experiments, cells were tested for mycoplasma contamination with LookOut Mycoplasma PCR Detection Kit (Sigma-Aldrich #D9307). Chromatin Immunoprecipitation Assays with Sequencing (ChIP-seq) ChIP-seq in LNCaP was performed as previously described 38 . Briefly, 10 million cells were fixed with 1% formaldehyde at room temperature for 10 min, quenched, and collected in lysis buffer (1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS and protease inhibitor [#11873580001, Roche] in PBS). Chromatin was sonicated with a Covaris E220 sonicator (140PIP, 5% duty cycle, 200 cycle burst). The sample was then incubated with antibodies (AR: Abcam ab133273, FOXA1: Abcam ab23738, H3K27ac: Diagenode 3C15410196; H3K4me3: Diagenode 3C15410003) coupled with Dynabeads protein A and protein G beads (Life Technologies) at 4 o C. Incubated chromatin was washed with RIPA wash buffer (100 mM Tris pH 7.5, 500 mM LiCl, 1% NP-40, 1% sodium deoxycholate) for 10 min six times and rinsed with TE buffer (pH 8.0) once. DNA was purified using a MinElute column followed by incubation in the de-crosslinking buffer (1% SDS, 0.1 M NaHCO3 with Proteinase K and RNase A) at 65 o C. Eluted DNA was prepared as sequencing libraries with the ThruPLEX-FD Prep Kit (Takara bio, # R400675). Libraries were sequenced with 150-BP PE on an Illumina HiSeq 2500 Sequencing platform at Novogene. RNA-Seq LNCaP cells (5x10^5) were harvested for RNA-seq 39 . Total RNA was collected from the cells using an RNeasy kit (Qiagen, #74104,) with DNase I treatment (Qiagen, #79254). The library preparations, quality control, and sequencing on HiSeq 2500 Sequencing platforms (150-BP PE) were performed by Novogene. Assay for transposase-accessible chromatin with sequencing (ATAC-seq) LNCaP cells were isolated and subjected to modified ATAC–seq as previously described 38 . Briefly, 50,000 nuclei were pelleted and resuspended in ice-cold 50µl of lysis buffer (10 mM Tris-HCl, pH 7.5, 10mM NaCl, 3mM MgCl2, 0.1% NP-40, 0.1% Tween20, and 0.01% Digitonin). The subsequent centrifugation was performed at 500 g for 10 min at 4°C. The nuclei pellets were resuspended in 50µl of transposition buffer (25µl of 2× TD buffer, 22.5µl of distilled water, 2.5 µl of Illumina Tn5 transposase) and incubated at 37°C for 30 min with shaking at 1000 rpm for fragmentation. Transposed DNA was purified with the MinElute PCR Purification kit (Qiagen). DNA was purified using Qiagen MinElute (#28004), and the library was amplified up to the cycle number determined by 1/3rd maximal qPCR fluorescence. ATAC-seq libraries were sequenced with 150-BP PE high-throughput sequencing on an Illumina HiSeq 2500 Sequencing platform (Novogene). HiC combined with capture ChIP-seq (HiChIP) HiChIP was performed as previously described 39 . Trypsinized LNCaP cells (10 million) were fixed with 1% formaldehyde at room temperature for 10 min and quenched. The sample was lysed in HiChIP lysis buffer and digested with MboI (NEB) for 4 h. After 1 h of biotin incorporation with biotin dATP, the sample was ligated with T4 DNA ligase for 4 h with rotation. Chromatin was sonicated using Covaris E220 (conditions: 140 PIP, 5% DF, 200 CB) to 300–800 bp in ChIP lysis buffer (1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS and protease inhibitor in PBS) and centrifuged at 13,000 rpm. for 10 minutes at 4°C. Preclearing 30µl of Dynabeads protein A/G for 1 h at 4°C was followed by incubation with antibodies (H3K27ac, Diagenode, 3C15410196; H3K4me3, Diagenode 3C15410003). Reverse-crossed IP sample were pulled down with streptavidin C1 beads (Life Technologies), treated with Transposase (Illumina) and amplified with reasonable cycle numbers based on the qPCR with a 5-cycle pre-amplified library. The library was sequenced with 150-BP PE reads on the Illumina HiSeq 2500 Sequencing platform (Novogene). Small Capped Nascent RNA Sequencing (Start-seq) For Start-seq, LNCaP cells were grown and collected as described as above. Cell pellets were washed with ice-cold 1x PBS. 1 million cells were treated with 1.5mL of Nun Buffer (0.3M NaCl, 1M Urea, 1% NP-40, 20mM HEPES pH 7.5, 7.5mM MgCl2, 0.2M EDTAm, protease inhibitors and 20U/mL SUPERase-IN) for 30 min on ice with frequent vortexing. Chromatin was pelleted by centrifugation at 12500 g for 30 min for 4°C. After 3 times-washing with 1mL ice-cold chromatin washing buffer (50mM Tris-HCL pH7.5 and 40U/mL SUPERase-In) and additional 0.5mL of Nun buffer. After centrifugation for 5 min at 500 g, 0.5m TRIzol was added to the remaining pellet. Libraries were prepared according to the TruSeq Small RNA Kit (Illumina). To normalize samples, 15 synthetic capped RNAs were spiked into the Trizolpreparation at a specific quantity per 10^7 cells, as in 40 . The library was sequenced with 150-BP PE reads on the Illumina HiSeq 2500 Sequencing platform (Novogene). CRISPRi Guide RNAs (gRNAs) were designed for each enhancer and promoter region using CRISPR-SURF 41 . Cas-OFFinder was used to eliminate off-target gRNAs 42 . LNCaP cells stably expressing dCas9-KRAB (Addgene #89567) were seeded in a 6-well plate at a density of 200K cells per well. For transfection, a total of 500-1500ng DNA was used, divided according to the number of available gRNAs. Transfection was performed using Mirus TransIT-X2. After transfection, the media was replaced and 2ng/µl of puromycin was added for selection. Following 72 h of selection, the medium was changed to charcoal-stripped serum for androgen deprivation. After 48 h, the cells were treated with 10nM DHT for 4 h and then trypsinized. RNA extraction and cDNA preparation was performed using the LunaScript® RT SuperMix Kit. The androgen-induced expression was quantified using qRT-PCR and each experiment was conducted in triplicate. The sequences of gRNAs and qRT-PCR primers can be found in Supp Table 1 . Bioinformatics Analyses RNA-seq analysis Reads were aligned to the hg19 human genome with STAR (v2.7.9) 43 with quant mode (--quantMode TranscriptomeSAM). Next, “toTranscriptome” bam files were fed into Salmon (v0.14.1) 44 to quantify TPM values for (Gencode v19) 45 transcripts. To generate the signal track files from RNA-seq, VIPER 46 is used. Briefly, STAR as the default aligner, converts BAM files into BigWig files using Bedtools (v2.30.0) 47 . ChIP-seq and ATAC-seq analyses ChIP-seq and ATAC-seq were processed through the ChiLin pipeline 48 . Briefly, Illumina Casava1.7 software used for base calling and raw sequence quality and GC content were checked using FastQC (v0.10.1). The Burrows–Wheeler Aligner (BWA 49 , v0.7.10) was used to align the reads to the human genome hg19. Then, MACS2 50 (v2.1.0.20140616) was used for peak calling with an FDR q-value threshold of 0.01. Bed files and Bigwig files were generated using bedGraphToBigWig 51 and the union of narrow and broad peaks from ChIP-seq were used as anchors to call loops. The following quality metrics were assessed for each sample: (i) percentage of uniquely mapped reads, (ii) PCR bottleneck coefficient to identify potential over-amplification by PCR, (iii) FRiP (fraction of non-mitochondrial reads in peak regions), (iv) peak number, (v) number of peaks with 10-fold and 20-fold enrichment over the background, (vi) fragment size, (vii) the percentage of the merged peaks with promoter, enhancer, intron, or intergenic, and (viii) peak overlap with DNaseI hypersensitivity sites. For datasets with replicates, the replicate consistency was checked by two metrics: 1. Pearson correlation of reads across the genome using UCSC software wigCorrelate after normalizing signal to reads per million and 2. percentage of overlapping peaks in the replicates. HiChIP Loop calling After trimming adaptors from the HiChIP datasets using Trim Galore (v0.5.0) ( https://github.com/FelixKrueger/TrimGalore ), we used HiC-Pro (v3.1.0) 52 as previously described in Giambartolomei and Seo et al. 39 . This aligned the reads to the hg19 human genome, assigned reads to MboI restriction fragments, and removed duplicate reads. We used the following options: <MIN_MAPQ = 20, BOWTIE2_GLOBAL_OPTIONS = –very-sensitive–end-to-end–reorder, BOWTIE2_LOCAL_OPTIONS = –very-sensitive–end-to-end–reorder, GENOME_FRAGMENT = MboI_resfrag_hg19.bed, LIGATION_SITE = GATCGATC, LIGATION_SITE = “GATCGATC,” BIN_SIZE = “5000.”> All other default settings were used. To build the contact maps, the HiC-Pro pipeline selects only uniquely mapped valid read pairs involving two different restriction fragments. We applied FitHiChIP (v10.0) 53 for bias-corrected peak and DNA loop calls. FitHiChIP models the genomic distance effect with a spline fit, normalizes for coverage differences with regression, and computes statistical significance estimates for each pair of loci. We used the FitHiChIP loop significance model to determine whether interactions are significantly stronger than the random background interaction frequency. As anchors to call loops in the HiChIP analyses, we used 842367 regions for H3K27ac and 136939 regions for H3K4me3, which resulted from merging ChIP-seq narrow and broad peaks comprised 2 replicates for each broad and narrow peak and each of the five-time points (0m, 30m, 4h, 16h, 72h) for H3K27ac, and 1 replicate for each broad and narrow peak and each of the same time points for H3K4me3. We used a 5 kb resolution and considered only interactions between 5 kb and 3 Mb. We used the peak to all for the foreground, meaning at least one anchor needed to be in the peak rather than both. The corresponding FitHiChIP options specification is For the global background estimation of expected counts (and contact probabilities for each genomic distance), FitHiChIP can use either peak-to-peak (stringent) or peak-to-all (loose) loops for learning the background and spline fitting. We specified the suggested option to merge interactions close to each other to represent a single interaction when their originating bins are closer. The corresponding FitHiChIP options specifications are and (FitHiChIP (L + M)). We used the default FitHiChIP q value < 0.01 to identify significant loops. We used hicpro2higlass (v3.1.0) to convert allValidPairs to .cool files after having specified the hg19 chromosome sizes, using the following command: The reads from HiChIP data were merged from every time point for H3K27ac and H3K4me3 separately, and the reference loop sets were called with the same parameters above (resulting loop number, n = 296,326; n = 278,491 respectively). Next, the contact frequency values of each time point at loops are captured from the .cool files using the Python package, Cooler (v0.9.3). The count table was then TMM normalized among time points to reduce the between-sample variation. Annotation of Cis-Regulatory Elements / Defining Background Genes CREs were defined as +/- 2.5 kb around the summit of the accessible region from ATAC-seq peaks at any given time point. Promoters were defined with a multi-step process. First, we identified the highest expression transcript (Gencode v19) 45 isoforms using Salmon (v0.14.1) 44 , see RNA-seq analysis. Next, the start locations -according to strand information- of the highest expressing transcripts were collected and the summit was extended +/2.5 kb. If they overlap with a defined CRE, we assigned the overlapping CRE as the active promoters. From these annotated active promoters, the genes of HALLMARKS_ANDROGEN_RESPONSE from the Molecular Signature Database (MSigDB) 54 were defined as AR-regulated genes. The transcriptome was divided into four quartiles and AR-regulated genes were compared with similarly expressing genes ( Supp Fig. 1A, B ). Overlapping CREs to an AR ChIP-seq peaks at any time point were defined as potential AR-bound enhancers. The median number AR-bound enhancers (E + AR; ~2) of AR-regulated genes were less than AR-free enhancers (E-AR; ~14) ( Supp Fig. 1E ). Similarly, a CRE was considered FOXA1-bound, if it intersects with a FOXA1 peak at any time point ( Supp Fig. 1C ). To identify down-regulated genes, we calculated the log2foldChange induction between 16h and 0m, considering those with a value below − 1 as downregulated genes ( Supp Fig. 3A, B ). Constructing the Graph Network When we called significant loops from each time point separately, there were few called loops overlapping between time points potentially due to both the loop calling methodologies and experimental noise present in HiChIP data 55 . As we could observe the matching loops in the contact matrices of all time points ( Supp Fig. 5 ), we instead generated a reference loop set, normalized the count matrix, and compared contact frequencies similar to published work 20 . A custom R (v4.1.1) script ( https://github.com/lacklab/AR_transcription ) was used to extract interaction pairs of annotated CRE regions (BED) according to the reference loop set (BEDPE; both H3K27ac and H3K4me3) using `GenomicInteractions` (v1.34) 56 . The graph structure is built in custom Python (v3.9.7) script (link) using the NetworkX (v3.1) package 57 . Briefly, any pair of CREs are included as nodes in the network with TMM normalized HiChIP contact frequency as weighted edges, for both H3K27ac and H3K4me3 at every time point. Epigenetic changes of CREs and kinetic changes of enhancers of AR-regulated genes The average signal (AR, FOXA1, H3K27ac, H3K4me3, ATAC) at the promoters and CREs were collected using a custom python package ( https://github.com/breambio/bluegill ). To reduce the batch effect across time, TMM normalization was applied individually for each epigenetic factor 58 . To visualize the temporal change upon androgen stimulation, line plots were drawn ( Fig. 2 ). For the selected six AR-regulated genes ( Fig. 3F ), both the average signal (AR, FOXA1, H3K27ac, H3K4me3, ATAC) over the first-degree interacting enhancers of each gene promoter and contact frequency (CF) between every gene promoter and corresponding enhancer were collected for every time point. The standard deviation (SD) of each feature along the time domain was calculated and min-max normalized. Calculation of chromatin contact frequency change Promoter-centric analysis was done with the query loop sets, AR-regulated genes’ promoter loops (P + AR), and random highly expressed genes’ promoter loops (P-AR; n = 100 ; seed = 7). This was compared to reference loop sets (n = 100) that was randomized (1000 iterations; seed = 7) from highly expressed genes’ promoter loops ( Fig. 3B ). Fold change was calculated for each iteration between the average contact frequency of loops in the query and reference. The same approach was used to calculate the contact frequency fold change from the enhancer viewpoint. The loop sets were selected according to the E-P pairs. While selecting the query and reference loops, the number of randomly selected promoters was fixed (n = 100). The loops between AR-regulated gene promoters to AR-bound (E + AR) and AR-free enhancers (E-AR), and between AR-independent gene promoters to AR-free enhancers (E-AR) were compared to randomized loops from an AR-free enhancer to highly expressed gene promoters (1000 iterations; seed = 7). Start-seq analysis Adaptor sequences and low-quality 3′ ends were removed from paired-end reads of all samples using cutadapt (v1.2.1). Reads shorter than 20 nucleotides were discarded (-m 20 -q 10), and a single nucleotide was trimmed from the 3′ end of all remaining reads to enable successful alignment with bowtie (v1.1.1). The first in pair flagged reads were filtered to generate signal (bigwig) files for each strand using bedtools genomecov (-bg -5 -strand +/-, respectively). The transcripts (Gencode v19) were extracted GTF file. The maximum signal within a range of +/- 500 bp of TSS was gathered from the forward Start-seq track for plus-stranded transcripts, and the reverse for minus-stranded transcripts. Next, the log2foldchange (LFC), compared to 0m, was calculated for every time point (30m, 4h, 16h, 72h). If a transcript was found to be LFC > 1 at any time point, it was considered as differential up regulation. Next, the nascent expression levels at all time points for those transcripts (the union of differential up-regulation) were z-normalized to capture the highest expression time point, which is assigned to time-based expression groups ( Fig. 4A ). Similar to enhancer viewpoint analysis, the first-degree AR-bound enhancer contact frequency to the gene promoters was compared to randomly selected contact frequencies (1000 iterations) between the highly expressed gene promoters (n = 100) and their first-degree AR-free enhancers. Contact frequency, expression correlation To explore the contact frequency vs. expression, we performed three first-degree summarization models (average, maximum, and sum). Briefly, we identified all first-degree contacts of every gene promoter, then we summarized the contact frequencies with the corresponding function of the models for every gene. To reduce the signal noise, we first sorted genes according to expression, binned them into equal-sized sets (k = 25), plotted bins as a scatter plot with average log expression on the x-axis, and averaged summarized contact frequency on the y-axis ( Fig. 5B, Supp Fig. 7 ). Random Forest Regressor The binned (k = 25) contact frequency and expression data (see above) were used to train a random forest regressor from the Sklearn (v1.3.1) 59 with “random_state = 0”. The permutation importance of each feature is also calculated within the Sklearn 60 . Gini Index Analysis The chromatin contact frequency between gene promoter and first-degree interacting elements was identified and the Gini index was calculated for a 16h time-point ( Fig. 5C ). To calculate the Gini index a custom python function was utilized ( https://github.com/lacklab/AR_transcription ). The mean absolute difference is the average absolute difference between all pairs of items in the population. The relative mean absolute difference is obtained by dividing the mean absolute difference by the population's average ( \(\overline{x}\) ) to account for differences in scale (e.q 1), where \({x}_{i}\) is contact frequency of a loop i , and there are n loops of a promoter. $$G= \frac{\sum _{i=1}^{n}\sum _{j=1}^{n}\left|{x}_{i}-{x}_{j}\right|}{2{n}^{2}\overline{x}}$$ Circle Plots Circle plots were drawn with NetworkX and Matplotlib libraries 57,61 ( https://github.com/lacklab/AR_transcription ). Statistical analysis The probability of finding k loops from each CREs was determined by hypergeometric distribution ( Supp Fig. 4 ). When comparing the target set with the background set, a non-parametric Mann-Whitney-U test was applied. Correlation coefficients and their p-values were calculated with Spearman’s test. All statistical tests were performed using the SciPy (v1.11.1) Python package 62 . RESULTS Generation of androgen-stimulation kinetic dataset and construction of regulatory networks To characterize the temporal impact of AR binding on epigenetic features and chromatin looping, we generated an extensive kinetic multi-omics experimental dataset following androgen stimulation. We treated LNCaP cells with dihydrotestosterone and collected cells at 5 different time points (0m, 30m, 4h, 16h, 72h). At each time point, multiple features were characterized including gene expression (RNA-seq), chromatin accessibility (ATAC-seq), transcription factor binding and post-translational histone modification (AR, FOXA1, H3K27ac and H3K4me3 ChIP-seq), chromatin looping (HiChIP) and capped nascent RNA (Start-seq) ( Fig. 1A ). From these datasets, CREs (n = 78,522) were defined from accessible sites (ATAC-seq) 15 . Based on known gene annotations and AR ChIP-seq, CREs were annotated as either promoters (n = 13,575), AR-free CREs (n = 58,265), or AR-bound CREs (n = 6,682). The interaction between these CREs was defined from consensus H3K27ac (enhancer-centric; n = 296,326) and H3K4me3 (promoter-centric; n = 278,491; see methods) HiChIP loop sets. Supporting that these histone marks are associated with different functional CREs, only 23% of loops were found in both H3K27ac and H3K4me3 HiChIP ( Fig. 1B ). As expected, H3K27ac loops were predominantly between enhancer-enhancer (E-E) pairs, accounting for 43.2% of the loops, followed by enhancer-promoter (E-P) pairs, which constituted around 40.4% ( Fig. 1C ). In contrast, H3K4me3 loops were primarily between E-P pairs, making up 58.8% of the total loops. This is consistent with the known associations of these histone marks to promoter and enhancer CREs 63–65 . To allow more quantitative analyses of these large-scale chromatin interactions we transformed the resulting HiChIP looping data into a graphical network with each node representing a CRE and the edges being the chromatin loops between these two elements ( Fig. 1D ). With this regulatory network, we then overlaid the various multi-omics datasets to provide a framework that can interrogate the impact of AR binding. We investigated androgen-driven AR-mediated gene transcription based on the previously characterized hallmark androgen-responsive genes ( Supp Fig. 1A, B ). As expected, these were induced compared to similarly expressed random AR-independent genes ( Fig. 1E ). This comprehensive multi-omics dataset and graphical regulatory network provided a framework to quantitatively investigate the temporal impact of AR binding on epigenetic features, chromatin looping, and gene expression. Androgen stimulation leads to stepwise epigenetic changes With this structured regulatory network, we then explored how AR binding affects each epigenetic feature and its relationship with gene transcription. The AR-regulated genes’ promoters (P + AR) and their looped AR-bound enhancers (E + AR) were compared to randomly matched from highly expressed AR-independent genes’ promoters (P-AR) and their looped AR-free enhancer (E-AR) ( Fig. 2A ). We observed that E + AR displayed a strong AR and FOXA1 signal following androgen stimulation, that reached its peak at 4h and then subsequently decreased at 16h and 72h. Emphasizing FOXA1's pioneering activity, E + AR displayed elevated FOXA1 signal at the initial time point (0m). As expected, the AR and FOXA1 signal did not significantly change at AR-independent promoters or AR-free enhancer. Interestingly, those FOXA1-bound CREs that were not co-occupied by AR had no change in the relative FOXA1 signal ( Supp Fig. 1C, D ), suggesting that AR potentially influences FOXA1 occupancy 66 . As expected, we observed a higher H3K4me3 ChIP-seq signal at promoters compared to enhancers. This signal was largely unaffected by AR binding, but there were selective genes, including KLK3 , which exhibited an increasing H3K4me3 mark at its promoter following androgen treatment ( Supp Fig. 2 ). We observed an elevated H3K27ac signal at promoters compared to enhancers ( Fig. 2A ). Further, the H3K27ac signal increased specifically at E + AR, while it remained unchanged at E-AR. This change at E + AR was also observed for chromatin accessibility (ATAC-seq), though the maximum signal (16h) was found to occur after AR and FOXA1 peak occupancy (4h). We also investigated the epigenetic changes of AR down-regulated gene promoters and their AR-bound enhancers ( Supp Fig. 3A, B) . Interestingly, we observed that the AR-bound CREs (E + dAR), that were looped to the promoter of down-regulated genes (P + dAR) displayed a very similar increase in AR, FOXA1, H3K27ac, and chromatin accessibility ( Fig. 2B ). There was no statistically significant change at any time point in the AR-bound enhancers of either up or downregulated genes ( p > 0.1 ). Overall, these kinetic datasets show that there is a sequential process that occurs following androgen stimulation where AR, FOXA1, and H3K27ac signals selectively increase at looped enhancers before inducing subsequent changes in chromatin accessibility. AR-bound enhancers increase contact frequency to AR-upregulated gene promoters We first investigated how chromatin looping changed following AR activation. Initially, we compared the number of loops formed following androgen stimulation. We found that both promoters of AR-regulated genes (P + AR) and their looped AR-bound enhancers (E + AR) did not exhibit any significant changes ( p > 0.05) in the number of loops compared to background P-AR/E-AR ( Fig. 3A ). Supporting this, there was no significant difference in the distribution of the number of loops on gene promoters during androgen treatment ( Supp Fig. 4A ). These results demonstrate that AR binding does not cause a substantial rewiring of chromatin looping. While androgen treatment did not significantly change the number of loops, we did observe an increase in contact frequency at AR-bound enhancers looped to AR-regulated genes ( Supp Fig. 5 ). To quantify these changes, we calculated the fold change in contact frequency compared to bootstrapped ( b = 1000) random AR-independent genes from both promoter and enhancer viewpoints ( Fig. 3B ). We observed that AR activation increased the contact frequency of loops at AR-regulated promoters (P + AR) over time, with a peak at 16h (H3K27ac: p < 0.001; H3K4me3: p < 0.001) ( Fig. 3C ). In contrast, the change in contact frequency of loops to promoters of AR independent genes (P-AR) remained stable. From an enhancer viewpoint ( Fig. 3D ), AR-bound enhancer CREs (E + AR) showed a significant increase in both H3K27ac and H3K4me3 contact frequency (H3K27ac: p < 0.001; H3K4me3: p < 0.001). In contrast, AR-free CREs (E-AR; grey) that were connected to the same AR-regulated gene promoters did not exhibit any significant change. Further, no change in contact frequency was observed in the CREs (E-ARi; black) that interact with AR-independent gene promoters. While chromatin contact frequency increased between AR-bound enhancer CREs (E + AR) and upregulated hallmark gene promoters (P + AR), we did not observe any change in loops between AR-bound CREs (E + dAR) and downregulated gene promoters ( Fig. 3E ). This is particularly striking as, AR-bound CREs (E + AR, E + dAR) exhibited a similar pattern in their epigenetic profiles, regardless of whether they looped to an upregulated or downregulated gene ( Fig. 2A, Fig. 2B ). Given that a similar trend is observed at all AR-bound CREs, this suggests that epigenetic modifications must be combined with chromatin looping to contribute to gene expression. To interrogate the kinetic changes in epigenetics and contact frequency we focused on several up-regulated androgen-responsive genes ( KLK2 , KLK3 , NKX3-1 , UAP1 , ABCC4 , and DHCR24 ) ( Fig. 3F ). As expected, AR-free enhancers (E-AR; grey) had minimal changes in epigenetics and contact frequency. Interestingly, we observed that AR-bound enhancers (E + AR; orange) had broad heterogeneity in response to treatment. The same enhancer typically had both the highest change in epigenetic features and contact frequency. Our findings demonstrate that AR-bound enhancers increase contact frequency with AR-regulated gene promoters in response to androgen treatment. However, this response is heterogeneous and there is significant variability among AR-bound enhancers. Association of nascent transcription to epigenetic changes and contact frequency To determine if the change in contact frequency precedes or occurs simultaneously with AR-mediated gene transcription, we characterized the kinetic rate of androgen-induced gene expression. We identified up-regulated androgen-induced genes from nascent RNA (Start-seq) and categorized them based on the maximal expression (30m, 4h, 16h or 72h) ( Fig. 4A ). We chose to group these genes based on nascent RNA, as RNA-seq provides only steady-state quantification of mRNA transcripts 67 . Between these groups, no significant difference was observed in the maximal signal at AR-bound enhancers for AR, FOXA1 and H3K27ac ChIP-seq or chromatin accessibility ( Fig. 4B ), suggesting that the epigenetic features do not dictate the timing of maximal nascent RNA production. However, we observed a temporal relationship between nascent transcription and chromatin contact frequency. Specifically, the maximal nascent transcription (4h and 16h groups) occurred simultaneously with an increase in H3K27ac and came before the peak of H3K4me3 (16h) maximal contact frequency at AR-bound enhancers ( Fig. 4C ). These observations indicate that the change in contact frequency does not precede RNA transcription. Overall, these findings suggest that although AR and FOXA1 rapidly bind at enhancers upon androgen treatment, the maximal transcription occurs either simultaneously with or before a maximal alteration in chromatin contact frequency. Multi-enhancers influence transcription proportional to contact frequency Having observed marked heterogeneity in chromatin loop contact frequency at AR-bound enhancers, we began to explore the impact of multi-enhancer contacts on gene expression. We expand the scale of our analysis across all detectable genes (n = 13,575), and characterized how loop frequency correlates to gene expression. Most genes had multiple CREs interacting with target promoters with a median frequency of ~ 15 interactions per gene ( Supp. Figure 6A ). With this large dataset, we evaluated three models correlating H3K27ac and H3K4me3 contact frequency to gene expression where: all interactions contribute equally to gene expression (average), only a single strong interaction affects gene expression (maximum) and all interactions contribute to gene expression in an additive manner (sum) ( Fig. 5A ). While all models strongly correlated H3K27ac and H3K4me3 contact frequency to gene expression ( p < 0.0001; Spearman’s test), we found that the sum model (H3K27ac; r = 0.896, H3K4me3; r = 0.904) and maximum model (H3K27ac; r = 0.839, H3K4me3; r = 0.876) correlated significantly better than the average model (H3K27ac; r = 0.643, H3K4me3; r = 0.679) across all time points ( Fig. 5B and Supp Fig. 7 ). To quantify the importance of each feature, we built a random forest regressor to predict the expression from these operations (Accuracy; r 2 = 0.805) and found that the additive model (sum) best-predicted expression ( Supp Fig. 6B ) 68 . However, as we observed similar correlation with the maximum model, which scored only a single chromatin loop, this suggested that the contact frequency of chromatin loops to a promoter were markedly unbalanced and that there was a “dominant” interaction. To characterize this, we quantified the inequality of chromatin loop contact frequency to a target promoter and found that both H3K27ac and H3K4me3 were strongly unbalanced ( Gini > ~ 0.5; Supp Fig. 6C ). These findings suggest that enhancers interacting with gene promoters do not have a uniform distribution in contact frequency, and that there are “dominant” loops that strongly correlate with expression ( Fig. 5D ). To better understand how these potential dominant loops are dynamically affected by acute perturbation, we characterized the CRE-promoter interactions of androgen-regulated genes (n = 88; Supp Table 2 ). Dominant loops were identified for every gene promoter by first scaling the contact frequency of interacting CREs in the range (0, 1), and selecting the highest ones with a threshold (0.8). The dominant loops were not solely based on proximity to the gene promoter as they were the closest CRE in only 27% of AR-regulated genes (n = 24) at any time point. Suggesting that the dominant loops are “primed” before AR binds, the same dominant loops were commonly found at every time point ( Supp Fig. 8 ). Furthermore, we found that the dominant AR-bound CREs (D+) had significantly (p < 0.0001) higher dynamic change in contact frequency than non-dominant AR-bound CREs (D-) that interacts with AR-regulated gene promoters ( Fig. 5C ). Interestingly, the dominant loops were highly gene specific. When we characterized two AR-regulated genes, KLK3 and KLK2 , that share many looped CREs ( Fig. 5E ), we observed gene-specific disparities in contact frequency changes from an AR enhancer (ARBS3) to either the KLK2 or KLK3 promoters. While ARBS3 displayed the strongest and most dynamic contact frequency with the KLK2 promoter, it did not exhibit the strongest change for the KLK3 promoter. Instead, the loop with well-known upstream AR-enhancer 69 (ARBS2) dominates others. Interestingly, both dominant loop enhancers were not the CRE with the highest change in AR peak height, suggesting that there are additional factors that contribute to changes in contact frequency. Overall, these results demonstrate that AR binding does not affect chromatin looping equally and that those CREs with the most dynamic contact frequency potentially have a greater impact on gene transcription. CRISPR-based perturbations confirm the existence of “dominant” chromatin loops To experimentally validate these correlative models, we tested the effects of dominant chromatin loops on androgen-induced gene expression. Utilizing CRISPRi, a derivative of the CRISPR/Cas9 system that suppresses enhancer activity without altering DNA sequences, we inhibited all AR-bound enhancers (n = 20) that interact with ( Supp Table 1, Supp Fig. 9 ) the previously described AR-regulated genes ( KLK2 , KLK3 , NKX3-1 , UAP1 , ABCC4 , and DHCR24 ). Across all tested genes we found that inhibiting those CREs, that had a dominant chromatin loop, significantly impacted androgen-induced transcription ( Fig. 6A ). Importantly, as we observed highest dynamic change in contact frequency at ARBS3 and ARBS2 for KLK2 and KLK3, respectively ( Fig. 5E ), the highest gene expression inhibition is observed at these ARBSs. Supporting the kinetics of the dominance model, we observed an inverse correlation between the gene expression inhibition and the dynamic change in contact frequency of loops during androgen stimulation ( Fig. 6B ). This correlation was greater than other genomic features including AR, FOXA1, H3K4me3, H3K27ac and chromatin accessibility ( Supp Fig. 10 ). These results demonstrate that not all CREs contribute equally to androgen stimulation and that their contact frequency to promoters correlates with their impact on gene expression. Overall, these results underscore the importance of spatial genome organization in transcriptional regulation and validate our proposed multi-enhancer dominance model. DISCUSSION Transcription factors bind to specific DNA sites and regulate gene expression through the recruitment of co-regulatory proteins that activate transcriptional machinery 70,71 . Yet despite extensive research, many questions remain about how this complex process occurs, particularly as there are multiple CREs that interact with each promoter. Using the ligand-activated AR as a model system, we characterized how transcription factor activation changes the epigenetics and chromatin looping. Similar to published studies, our work showed that the AR stabilizes/recruits FOXA1 and increases both H3K27ac and chromatin accessibility ( Fig. 2A ) 2,5,7,72,73 . However, by characterizing a kinetic dataset, we showed that the change in chromatin accessibility occurs after both FOXA1/AR binding and H3K27ac post-translational modifications, suggesting that this is mediated by the recruitment of additional chromatin-remodeling proteins. Those enhancers that are not bound by AR do not exhibit these changes. However, these epigenetic changes do not solely drive gene expression, as we observed a consistent pattern in all AR-bound CREs, regardless of either the direction of expression (upregulated and downregulated), or timing of maximal nascent transcription ( Fig. 2; Fig. 4B ). These observations suggest a sequential mechanism, independent of gene expression, in which AR activation recruits specific co-regulatory proteins that alter histone modification and chromatin accessibility. This work also characterized how AR binding affects genome organization. This is a controversial field, with earlier studies proposing that steroid hormone receptors significantly reorganize chromatin looping when activated 74 . However, recent work has suggested that gene expression may occur through already-existing interactions 23 . Our research found that androgen treatment does not cause rewiring of chromatin contact loops but instead increases the contact frequencies of previously established loops ( Fig. 3C, D; Supp Fig. 5 ). Interestingly, we observed that maximal chromatin looping happens either during or after the maximal nascent gene expression ( Fig. 4C ). This suggests that increasing chromatin looping does not precede, but instead likely occurs simultaneously with gene transcription. Supporting this result, recent work observed that higher nascent RNA production is associated with a higher frequency of chromatin contacts 22 . Changes in the chromatin contact frequency have also been shown to be associated with differential gene expression 20,23 . Although several studies observed temporal changes in chromatin looping that occur before maximal RNA expression 21,23 , this distinction is likely due to the experimental methodology used, as RNA-seq primarily quantifies mature mRNA, whereas Start-seq captures only nascent mRNA. Highlighting the consistent pattern of epigenetic features of AR-bound enhancers ( Fig. 2; Fig. 4B ), we can infer chromatin looping is an additional mechanism which regulates gene expression independently of AR binding. The importance of chromatin loop contact frequency is highlighted when we look at AR-downregulated genes, which show similar changes in epigenetic alterations and chromatin accessibility but not contact frequency ( Fig. 2B; Fig. 3E ). This suggests that AR binding recruits additional factors that potentially increase the contact frequencies of pre-established loops between enhancers and their target gene promoters to regulate the gene expression. Numerous studies demonstrate that multiple enhancers contribute to the expression of a single gene 7,75 . However, there is no consensus about how each CRE contributes to gene expression. Our work suggests that connected enhancers contribute unevenly, and there exists dominant loops that have the largest impact on gene expression. These findings align with the assumptions made in the activity-by-contact (ABC) model 76 , which presumes that the enhancer’s impact on gene expression is correlated with the strength of the contact between them. Both our validation ( Fig. 6 ), and a recent large-scale CRISPRi study from Barshard et al. 22 , demonstrate that those enhancers with higher contact frequency to target promoters are more likely to be functionally important which suggest a “dominance” model ( Fig. 5D ). However, further improvements of this model can help us to understand the effect of individual CREs, thus allowing us to evaluate how multiple transcription factors impact gene expression. Given the complex nature of this system, we had to make several assumptions. First, we chose to define individual regulatory units based on chromatin accessibility, since defining enhancers and promoters by histone modifications is prone to false positives 77,78 . Within these CREs, we focused on hallmark androgen response genes ( Fig. 1E ), as these have been extensively demonstrated to be regulated by AR. Next, we used HiChIP, a protein-centric HiC method, rather than conventional HiC to provide enhanced resolution and specificity in capturing protein-bound chromatin 79 . By characterizing both promoter-centric (H3K4me3) and enhancer-centric (H3K27ac) chromatin loops, we believe this provided us with different genomic perspectives of chromatin loops and reduced potential biases ( Fig. 1B, C ) 21,80,81 . It is important to note that while H3K27ac is strongly impacted by AR binding we observed that H3K4me3 was relatively static ( Fig. 2; Fig. 4B ), suggesting that the change in contact frequency ( Fig. 3C-E ; Fig. 4C ) following androgen treatment was not due to capture efficiency. Finally, as gene expression regulation circuits are challenging to integrate due to the intricate network structures formed by diverse CREs ( Fig. 1D ), we utilized regulatory networks wherein the nodes and edges represent the CREs and chromatin loops, respectively. Several studies have employed graph-based approaches to connect genomic regions and address various high-dimensional biological inquiries 82–84 . The versatility of this approach underscores the quantitative advantages of utilizing graphs to characterize chromatin loops. Despite these limitations, this study represents one of the largest experimental datasets ( Fig. 1A ) to characterize AR-mediated transcription. Overall, this paper provides new insight into several important aspects of AR-mediated gene expression. We show that AR binding triggers a temporal cascade which increases FOXA1 and H3K27ac that affects chromatin accessibility. Further, we demonstrate that AR does not introduce novel chromatin loops, but instead increases the contact frequency between AR-bound enhancers and their target promoters. However, the effect of each enhancer on gene expression is markedly heterogeneous and proportional to promoter contact frequency. These findings suggest that while AR binding to DNA induces a step-wise epigenetic alteration, the impact of bound enhancers is strongly dependent on the contact frequency of the established chromatin loops with the target promoter. Declarations ACKNOWLEDGMENTS N.A.L. was supported by funding from TUBITAK (221Z116), W81XWH-21-1-0234 (DoD), and CIHR PJT-173331. M.L.F. was supported by the Claudia Adams Barr Program for Innovative Cancer Research, the Dana-Farber Cancer Institute Presidential Initiatives Fund, the H.L. Snyder Medical Research Foundation, the Cutler Family Fund for Prevention and Early Detection, the Donahue Family Fund, W81XWH-21-1-0339, W81XWH-22-1-0951 (DoD), NIH Awards R01CA251555, R01CA227237, R01CA262577, R01CA259058 and a Movember PCF Challenge Award. AUTHOR CONTRIBUTIONS Conceptualization, M.L.F., N.A.L.; Methodology, U.B.A., J.S., C.G.; Validation, D.O., Formal analysis, U.B.A., C.G., G.M.N.; Investigation, J.S., D.O., S.R.G.; Resources, K.A.; Data curation, J.S., B.J.F., U.B.A.; Writing – Original Draft, U.B.A.; Writing – Review & Editing, J.S., C.G., D.O., B.J.F., G.M.N., S.R.G., K.A., F.H., M.F.L., N.A.L.; Visualization, U.B.A., N.A.L.; Supervision, K.A., F.H., M.F.L., N.A.L.; Funding Acquisition M.F.L., N.A.L. DECLARATION OF INTERESTS The authors declare no competing interests. References Nelson, P. S. et al. The program of androgen-responsive genes in neoplastic prostate epithelium. Proc. Natl. Acad. Sci. U. S. A. 99 , 11890–11895 (2002). Davey, R. A. & Grossmann, M. Androgen Receptor Structure, Function and Biology: From Bench to Bedside. Clin. Biochem. Rev. 37 , 3–15 (2016). Georget, V., Térouanne, B., Nicolas, J.-C. & Sultan, C. Mechanism of antiandrogen action: key role of hsp90 in conformational change and transcriptional activity of the androgen receptor. Biochemistry 41 , 11824–11831 (2002). Ozanne, D. M. et al. Androgen receptor nuclear translocation is facilitated by the f-actin cross-linking protein filamin. Mol. Endocrinol. 14 , 1618–1626 (2000). Teng, M., Zhou, S., Cai, C., Lupien, M. & He, H. H. Pioneer of prostate cancer: past, present and the future of FOXA1. Protein Cell 12 , 29–38 (2021). Sahu, B. et al. Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer. EMBO J. 30 , 3962–3976 (2011). Stelloo, S., Bergman, A. M. & Zwart, W. Androgen receptor enhancer usage and the chromatin regulatory landscape in human prostate cancers. Endocr. Relat. Cancer 26 , R267–R285 (2019). Wilson, S., Qi, J. & Filipp, F. V. Refinement of the androgen response element based on ChIP-Seq in androgen-insensitive and androgen-responsive prostate cancer cell lines. Sci. Rep. 6 , 32611 (2016). Heinlein, C. A. & Chang, C. Androgen receptor (AR) coregulators: an overview. Endocr. Rev. 23 , 175–200 (2002). Jin, H.-J., Kim, J. & Yu, J. Androgen receptor genomic regulation. Transl. Androl. Urol. 2 , 157–177 (2013). Kadauke, S. & Blobel, G. A. Chromatin loops in gene regulation. Biochim. Biophys. Acta 1789 , 17–25 (2009). Zhu, I., Song, W., Ovcharenko, I. & Landsman, D. A model of active transcription hubs that unifies the roles of active promoters and enhancers. Nucleic Acids Res. 49 , 4493–4505 (2021). Sahu, B. et al. Sequence determinants of human gene regulatory elements. Nat. Genet. 54 , 283–294 (2022). Morgan, M. A. J. & Shilatifard, A. Reevaluating the roles of histone-modifying enzymes and their associated chromatin modifications in transcriptional regulation. Nat. Genet. 52 , 1271–1281 (2020). Tsompana, M. & Buck, M. J. Chromatin accessibility: a window into the genome. Epigenetics Chromatin 7 , 33 (2014). Wang, H. et al. H3K4me3 regulates RNA polymerase II promoter-proximal pause-release. Nature 615 , 339–348 (2023). Tewari, A. K. et al. Chromatin accessibility reveals insights into androgen receptor activation and transcriptional specificity. Genome Biol. 13 , R88 (2012). Guo, H. et al. Androgen receptor and MYC equilibration centralizes on developmental super-enhancer. Nat. Commun. 12 , 7308 (2021). Sawada, T., Kanemoto, Y., Kurokawa, T. & Kato, S. The epigenetic function of androgen receptor in prostate cancer progression. Front Cell Dev Biol 11 , 1083486 (2023). Greenwald, W. W. et al. Subtle changes in chromatin loop contact propensity are associated with differential gene regulation and expression. Nat. Commun. 10 , 1054 (2019). Reed, K. S. M. et al. Temporal analysis suggests a reciprocal relationship between 3D chromatin structure and transcription. Cell Rep. 41 , 111567 (2022). Barshad, G. et al. RNA polymerase II dynamics shape enhancer–promoter interactions. Nat. Genet. 55 , 1370–1380 (2023). D’Ippolito, A. M. et al. Pre-established Chromatin Interactions Mediate the Genomic Response to Glucocorticoids. Cell Syst 7 , 146-160.e7 (2018). Stelloo, S. et al. Androgen receptor profiling predicts prostate cancer outcome. EMBO Mol. Med. 7 , 1450–1464 (2015). Pomerantz, M. M. et al. The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis. Nat. Genet. 47 , 1346–1351 (2015). Pomerantz, M. M. et al. Prostate cancer reactivates developmental epigenomic programs during metastatic progression. Nat. Genet. 52 , 790–799 (2020). Grbesa, I. et al. Reshaping of the androgen-driven chromatin landscape in normal prostate cells by early cancer drivers and effect on therapeutic sensitivity. Cell Rep. 36 , 109625 (2021). Huang, C.-C. F. et al. Functional mapping of androgen receptor enhancer activity. Genome Biol. 22 , 149 (2021). Staller, M. V. Transcription factors perform a 2-step search of the nucleus. Genetics 222 , (2022). Uyehara, C. M. & Apostolou, E. 3D enhancer-promoter interactions and multi-connected hubs: Organizational principles and functional roles. Cell Rep. 112068 (2023). Carey, M. The enhanceosome and transcriptional synergy. Cell 92 , 5–8 (1998). Merika, M. & Thanos, D. Enhanceosomes. Curr. Opin. Genet. Dev. 11 , 205–208 (2001). Choi, J. et al. Evidence for additive and synergistic action of mammalian enhancers during cell fate determination. Elife 10 , (2021). Antosova, B. et al. The Gene Regulatory Network of Lens Induction Is Wired through Meis-Dependent Shadow Enhancers of Pax6. PLoS Genet. 12 , e1006441 (2016). Cannavò, E. et al. Shadow Enhancers Are Pervasive Features of Developmental Regulatory Networks. Curr. Biol. 26 , 38–51 (2016). Hong, J.-W., Hendrix, D. A. & Levine, M. S. Shadow enhancers as a source of evolutionary novelty. Science 321 , 1314 (2008). Kvon, E. Z., Waymack, R., Gad, M. & Wunderlich, Z. Enhancer redundancy in development and disease. Nat. Rev. Genet. 22 , 324–336 (2021). Baca, S. C. et al. Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer. Nat. Commun. 12 , 1979 (2021). Giambartolomei, C. et al. H3K27ac HiChIP in prostate cell lines identifies risk genes for prostate cancer susceptibility. Am. J. Hum. Genet. 108 , 2284–2300 (2021). Dorighi, K. M. et al. Mll3 and Mll4 facilitate enhancer RNA synthesis and transcription from promoters independently of H3K4 monomethylation. Mol. Cell 66 , 568-576.e4 (2017). Hsu, J. Y. et al. CRISPR-SURF: discovering regulatory elements by deconvolution of CRISPR tiling screen data. Nat. Methods 15 , 992–993 (2018). Bae, S., Park, J. & Kim, J.-S. Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics 30 , 1473–1475 (2014). Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29 , 15–21 (2013). Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14 , 417–419 (2017). Frankish, A. et al. GENCODE 2021. Nucleic Acids Res. 49 , D916–D923 (2021). Cornwell, M. et al. VIPER: Visualization Pipeline for RNA-seq, a Snakemake workflow for efficient and complete RNA-seq analysis. BMC Bioinformatics 19 , 135 (2018). Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26 , 841–842 (2010). Qin, Q. et al. ChiLin: a comprehensive ChIP-seq and DNase-seq quality control and analysis pipeline. BMC Bioinformatics 17 , 404 (2016). Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics 25 , 1754–1760 (2009). Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9 , R137 (2008). Kent, W. J., Zweig, A. S., Barber, G., Hinrichs, A. S. & Karolchik, D. BigWig and BigBed: enabling browsing of large distributed datasets. Bioinformatics 26 , 2204–2207 (2010). Servant, N. et al. HiC-Pro: an optimized and flexible pipeline for Hi-C data processing. Genome Biol. 16 , 259 (2015). Bhattacharyya, S., Chandra, V., Vijayanand, P. & Ay, F. Identification of significant chromatin contacts from HiChIP data by FitHiChIP. Nat. Commun. 10 , 4221 (2019). Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 102 , 15545–15550 (2005). Yardımcı, G. G. et al. Measuring the reproducibility and quality of Hi-C data. Genome Biol. 20 , 1–19 (2019). Harmston, N., Ing-Simmons, E., Perry, M., Barešić, A. & Lenhard, B. GenomicInteractions: An R/Bioconductor package for manipulating and investigating chromatin interaction data. BMC Genomics 16 , 963 (2015). Hagberg, A., Swart, P. & S Chult, D. Exploring network structure, dynamics, and function using networkx . https://www.osti.gov/biblio/960616 (2008). Robinson, M. D. & Oshlack, A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 11 , R25 (2010). Buitinck, L. et al. API design for machine learning software: experiences from the scikit-learn project. arXiv [cs.LG] (2013). Breiman, L. Mach. Learn. 45 , 5–32 (2001). Hunter. Matplotlib: A 2D Graphics Environment. 9 , 90–95 (2007). Virtanen, P., Gommers, R., Oliphant, T. E. & Haberland, M. Fundamental algorithms for scientific computing in python and SciPy 1.0 contributors. SciPy 1.0. Nat. Methods . Liang, G. et al. Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome. Proc. Natl. Acad. Sci. U. S. A. 101 , 7357–7362 (2004). Creyghton, M. P. et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proceedings of the National Academy of Sciences vol. 107 21931–21936 Preprint at https://doi.org/10.1073/pnas.1016071107 (2010). Roadmap Epigenomics Consortium et al. Integrative analysis of 111 reference human epigenomes. Nature 518 , 317–330 (2015). Chen, Z. et al. Androgen Receptor-Activated Enhancers Simultaneously Regulate Oncogene TMPRSS2 and lncRNA PRCAT38 in Prostate Cancer. Cells 8 , (2019). Henriques, T. et al. Widespread transcriptional pausing and elongation control at enhancers. Genes & Development vol. 32 26–41 Preprint at https://doi.org/10.1101/gad.309351.117 (2018). Breiman, L. Random Forests. Mach. Learn. 45 , 5–32 (2001). Lawrence, M. G., Lai, J. & Clements, J. A. Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus. Endocr. Rev. 31 , 407–446 (2010). Reményi, A., Schöler, H. R. & Wilmanns, M. Combinatorial control of gene expression. Nat. Struct. Mol. Biol. 11 , 812–815 (2004). Sproul, D., Gilbert, N. & Bickmore, W. A. The role of chromatin structure in regulating the expression of clustered genes. Nat. Rev. Genet. 6 , 775–781 (2005). Cosgrove, M. S., Boeke, J. D. & Wolberger, C. Regulated nucleosome mobility and the histone code. Nat. Struct. Mol. Biol. 11 , 1037–1043 (2004). Glont, S.-E., Chernukhin, I. & Carroll, J. S. Comprehensive Genomic Analysis Reveals that the Pioneering Function of FOXA1 Is Independent of Hormonal Signaling. Cell Rep. 26 , 2558-2565.e3 (2019). Le Dily, F. & Beato, M. Signaling by Steroid Hormones in the 3D Nuclear Space. Int. J. Mol. Sci. 19 , (2018). Karnuta, J. M. & Scacheri, P. C. Enhancers: bridging the gap between gene control and human disease. Hum. Mol. Genet. 27 , R219–R227 (2018). Fulco, C. P. et al. Activity-by-contact model of enhancer-promoter regulation from thousands of CRISPR perturbations. Nat. Genet. 51 , 1664–1669 (2019). Andersson, R. & Sandelin, A. Determinants of enhancer and promoter activities of regulatory elements. Nat. Rev. Genet. 21 , 71–87 (2020). Oudelaar, A. M. & Higgs, D. R. The relationship between genome structure and function. Nat. Rev. Genet. 22 , 154–168 (2021). Mumbach, M. R. et al. HiChIP: efficient and sensitive analysis of protein-directed genome architecture. Nat. Methods 13 , 919–922 (2016). Mumbach, M. R. et al. Enhancer connectome in primary human cells identifies target genes of disease-associated DNA elements. Nat. Genet. 49 , 1602–1612 (2017). Crispatzu, G. et al. The chromatin, topological and regulatory properties of pluripotency-associated poised enhancers are conserved in vivo. Nat. Commun. 12 , 4344 (2021). Cao, Z.-J. & Gao, G. Multi-omics single-cell data integration and regulatory inference with graph-linked embedding. Nat. Biotechnol. (2022) doi:10.1038/s41587-022-01284-4. Pliner, H. A. et al. Cicero Predicts cis-Regulatory DNA Interactions from Single-Cell Chromatin Accessibility Data. Molecular Cell vol. 71 858-871.e8 Preprint at https://doi.org/10.1016/j.molcel.2018.06.044 (2018). Thibodeau, A., Márquez, E. J., Shin, D.-G., Vera-Licona, P. & Ucar, D. Chromatin interaction networks revealed unique connectivity patterns of broad H3K4me3 domains and super enhancers in 3D chromatin. Sci. Rep. 7 , 14466 (2017). Additional Declarations There is NO Competing Interest. Supplementary Files SuppFigs.pdf ARtranscriptionSuppTable1.pdf ARtranscriptionSuppTable2.pdf Cite Share Download PDF Status: Published Journal Publication published 03 Nov, 2024 Read the published version in Nature Communications → Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-3854707","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":269486030,"identity":"c8e9424d-3c46-406f-aea3-f5d3f1c95761","order_by":0,"name":"Nathan Lack","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA+UlEQVRIiWNgGAWjYDACdgYGxoYKkrQwg7ScgbIOgGg2YrQ0tpGixZyZ+eHHmfPu5PPznz/4+UOFnZy5fO/DBww1NtG4tFg2sxlLbtz2zHLmjGRmiQNnko0t29iNDRiOpeU24NBicJjBjPHhtsMGBjeYGSQOth1I3HCMjU2CseEwHi3s3xgfzgFqOX+Y+cfBfwfqgVrYf+DXwmPGuLEBqOVAMpvEwYYDCQZAWxgIaCmWnHHsmYHkjGQzizPHkg03HEtjlkjA55fj7Rs/9tTcMeDnP/j4RkWNnbzB4WOMHz7U2ODUAgUH0PgJ+JVj0zIKRsEoGAWjAAkAAFWmXMhVhWM7AAAAAElFTkSuQmCC","orcid":"","institution":"Vancouver Prostate Centre","correspondingAuthor":true,"prefix":"","firstName":"Nathan","middleName":"","lastName":"Lack","suffix":""},{"id":269486031,"identity":"a3571dc0-99f7-421c-9d49-3c48df42f9f4","order_by":1,"name":"Umut Berkay Altintas","email":"","orcid":"https://orcid.org/0000-0002-0861-5013","institution":"Vancouver Prostate Centre","correspondingAuthor":false,"prefix":"","firstName":"Umut","middleName":"Berkay","lastName":"Altintas","suffix":""},{"id":269486032,"identity":"feb7d397-f9e4-48ee-9a54-eb7d74c4922c","order_by":2,"name":"Ji-Heu Seo","email":"","orcid":"","institution":"Dana-Farber Cancer Institute","correspondingAuthor":false,"prefix":"","firstName":"Ji-Heu","middleName":"","lastName":"Seo","suffix":""},{"id":269486033,"identity":"2edcae7f-bbda-4640-b4ac-2378c747bf5e","order_by":3,"name":"Claudia Giambartolomei","email":"","orcid":"","institution":"Human Technopole","correspondingAuthor":false,"prefix":"","firstName":"Claudia","middleName":"","lastName":"Giambartolomei","suffix":""},{"id":269486034,"identity":"c20f3a63-f411-4879-a75f-f254accf42ef","order_by":4,"name":"Dogancan Ozturan","email":"","orcid":"","institution":"Vancouver Prostate Centre","correspondingAuthor":false,"prefix":"","firstName":"Dogancan","middleName":"","lastName":"Ozturan","suffix":""},{"id":269486035,"identity":"d8b23518-60a5-4ee4-a312-fef187a82b44","order_by":5,"name":"Brad Fortunato","email":"","orcid":"","institution":"Dana-Farber Cancer Institute","correspondingAuthor":false,"prefix":"","firstName":"Brad","middleName":"","lastName":"Fortunato","suffix":""},{"id":269486036,"identity":"79f8ac05-b886-4e6d-8363-4e860f05115b","order_by":6,"name":"Geoffrey Nelson","email":"","orcid":"https://orcid.org/0000-0001-9825-4241","institution":"Harvard Medical School","correspondingAuthor":false,"prefix":"","firstName":"Geoffrey","middleName":"","lastName":"Nelson","suffix":""},{"id":269486037,"identity":"efdaad58-e462-4a06-8c67-8cfaed563d49","order_by":7,"name":"Seth Goldman","email":"","orcid":"","institution":"Harvard Medical School","correspondingAuthor":false,"prefix":"","firstName":"Seth","middleName":"","lastName":"Goldman","suffix":""},{"id":269486038,"identity":"f524e7e3-f36a-4f0d-bd0d-7ff12211ac58","order_by":8,"name":"Karen Adelman","email":"","orcid":"https://orcid.org/0000-0001-5364-334X","institution":"Harvard Medical School","correspondingAuthor":false,"prefix":"","firstName":"Karen","middleName":"","lastName":"Adelman","suffix":""},{"id":269486039,"identity":"4c9ffeb4-f1a5-47c4-9860-0e19ee1557c9","order_by":9,"name":"Faraz Hach","email":"","orcid":"","institution":"Vancouver Prostate Centre","correspondingAuthor":false,"prefix":"","firstName":"Faraz","middleName":"","lastName":"Hach","suffix":""},{"id":269486040,"identity":"d4639ef9-072d-4423-9c7a-b7b3edf5554f","order_by":10,"name":"Matthew Freedman","email":"","orcid":"","institution":"Dana-Farber Cancer Institute","correspondingAuthor":false,"prefix":"","firstName":"Matthew","middleName":"","lastName":"Freedman","suffix":""}],"badges":[],"createdAt":"2024-01-11 20:45:16","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-3854707/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-3854707/v1","draftVersion":[],"editorialEvents":[{"content":"https://doi.org/10.1038/s41467-024-53758-5","type":"published","date":"2024-11-03T04:00:00+00:00"}],"editorialNote":"","failedWorkflow":false,"files":[{"id":50569859,"identity":"288c8bf4-ccdb-42d4-8a81-99d97ffb9876","added_by":"auto","created_at":"2024-02-02 15:35:42","extension":"jpg","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":857767,"visible":true,"origin":"","legend":"\u003cp\u003eDesign of temporal multi-omics dataset and construction of a bioinformatic framework. \u003cstrong\u003e(A)\u003c/strong\u003e Schematic representation of the experimental design. LNCaP cells were treated with 10nM DHT and samples were collected at 5 different time points (0m, 30m, 4h, 16h, 72h) for RNA-seq, ATAC-seq, ChIP-seq (AR, FOXA1, H3K27ac, H3K4me3), HiChIP (H3K27ac, H3K4me3) and Start-seq. \u003cstrong\u003e(B) \u003c/strong\u003eVenn diagram representing significantly called chromatin loops from merged H3K27ac and H3K4me3 HiChIP datasets. \u003cstrong\u003e(C) \u003c/strong\u003eArc plots representing percentages of promoter-promoter (P-P), enhancer/CRE-promoter (E-P), and enhancer/CRE-enhancer/CRE (E-E) loops for H3K27ac and H3K4me3 HiChIP. \u003cstrong\u003e(D) \u003c/strong\u003eGraphical representation of regulatory network. \u003cstrong\u003e(E)\u003c/strong\u003e Gene expression profile of androgen response hallmark genes (P+AR; red), highly expressed (first quartile; P-AR; black) and mid-high (second quartile; P-AR; grey) expressed genes at all time points.\u003c/p\u003e","description":"","filename":"1.jpg","url":"https://assets-eu.researchsquare.com/files/rs-3854707/v1/6606364a9c60564b3fa83ba3.jpg"},{"id":50569860,"identity":"2902718b-0967-45c6-ba5c-11965b0c4055","added_by":"auto","created_at":"2024-02-02 15:35:42","extension":"jpg","order_by":2,"title":"Figure 2","display":"","copyAsset":false,"role":"figure","size":690087,"visible":true,"origin":"","legend":"\u003cp\u003eActivation of the androgen receptor leads to a delayed increase in histone modifications and chromatin accessibility \u003cstrong\u003e(A) \u003c/strong\u003eTMM normalized ChIP-seq or ATAC-seq signal were compared across all time points at different regulatory elements including: Promoters of\u003cstrong\u003e \u003c/strong\u003eAR up-regulated genes (P+AR: red), promoters of AR-independent genes (P-AR: black),\u003cstrong\u003e \u003c/strong\u003eAR-bound enhancers (E+AR: yellow) of AR-regulated genes, AR-free enhancers (E-AR: grey) of AR-independent genes. \u003cstrong\u003e(B) \u003c/strong\u003eA similar analysis was done for the promoters of\u003cstrong\u003e \u003c/strong\u003eAR down-regulated genes (P+dAR: blue), and their AR-bound enhancers (E+dAR: yellow).\u003c/p\u003e","description":"","filename":"2.jpg","url":"https://assets-eu.researchsquare.com/files/rs-3854707/v1/79a95b74015be7990fbde750.jpg"},{"id":50570150,"identity":"1433b23e-733c-489b-8111-826f7bdd17a2","added_by":"auto","created_at":"2024-02-02 15:43:42","extension":"jpg","order_by":3,"title":"Figure 3","display":"","copyAsset":false,"role":"figure","size":1097248,"visible":true,"origin":"","legend":"\u003cp\u003eAR-bound enhancers increase contact frequency to AR-regulated gene promoters to upregulate gene expression\u003cstrong\u003e. (A) \u003c/strong\u003eKernel density estimation of the number of significantly called loop anchoring promoters (left; AR-regulated promoters are in red; AR-independent promoter backgrounds are in black) or enhancers (right; AR-bound enhancers are in yellow; AR-free CRE background are in grey) at each time point (H3K27ac HiChIP). Each row represents the significantly called loops at each time point separately, and not reference loops. \u003cstrong\u003e(B)\u003c/strong\u003e Schematic representation of fold change in contact frequency calculation for a given gene set (left), from its promoter’s viewpoint (middle), from its enhancers’ viewpoint (right). The query loop sets are compared to the same reference loop set. Promoter view: The AR-regulated gene promoter loops (red sticks) and a random set of AR-independent gene promoter loops (black sticks) are compared to the reference loops which are selected from AR-independent promoter loops (denominator black sticks). Enhancer view: The loops to AR-bound enhancers (yellow sticks) and AR-free enhancers (grey sticks) and loops of AR-free enhancers (black sticks) that interacting with AR-independent gene promoters are compared to the reference loops which are selected from AR-independent promoters that interact with AR-free enhancers (denominator black sticks). \u003cstrong\u003e(C) \u003c/strong\u003eFold change in chromatin loop contact frequency of AR-regulated gene promoters (P+AR; red) and highly expressed AR-independent gene promoters (P-AR; black). \u003cstrong\u003e(D)\u003c/strong\u003e Fold change in contact frequency of AR-bound enhancers that loop to AR-regulated genes (E+AR; yellow), AR-free enhancers looping to AR-regulated genes (E-AR; grey), and AR-free enhancers looping to highly expressed AR-independent genes (E-ARi; black) \u003cstrong\u003e(E) \u003c/strong\u003eFold change in contact frequency in AR-bound enhancers looping to AR-down-regulated genes (E+dAR; blue), and AR-free enhancers looping to highly expressed genes (E-ARi; black) \u003cstrong\u003e(F) \u003c/strong\u003eMin-max normalized standard deviation (SD) following androgen treatment for AR, FOXA1, H3K27ac and H3K4me3 ChIP-seq, ATAC-seq and H3K27ac and H3K4me3 HiChIP contact frequency (CF) are depicted for AR-bound (E+AR; orange) and AR-free (E-AR; grey) CREs of six selected AR-regulated genes (\u003cem\u003eKLK2, KLK3, NKX3-1, UAP1, ABBCC4, DHCR24\u003c/em\u003e).\u003c/p\u003e","description":"","filename":"3.jpg","url":"https://assets-eu.researchsquare.com/files/rs-3854707/v1/e54f6efc7dde751f8d066c53.jpg"},{"id":50570152,"identity":"0015fadf-4eb2-4e4f-8ff6-44c233ef3a21","added_by":"auto","created_at":"2024-02-02 15:43:42","extension":"jpg","order_by":4,"title":"Figure 4","display":"","copyAsset":false,"role":"figure","size":963193,"visible":true,"origin":"","legend":"\u003cp\u003eTemporal changes on epigenetics nascent RNA \u003cstrong\u003e(A) \u003c/strong\u003eClustering of\u003cstrong\u003e \u003c/strong\u003enascent capped mRNA (Start-seq) according to time-dependent maximum expression. The union of upregulated transcripts’ nascent expression level across all time points were z-score normalized. \u003cstrong\u003e(B) \u003c/strong\u003eTMM normalized ChIP-seq or ATAC-seq of the following regulatory elements: AR-bound enhancers (E+AR: yellow) and AR-free enhancers (E-AR: grey). Each row represents the enhancers that loop to those genes that are maximally expressed at that time point (see A).\u003cstrong\u003e (C)\u003c/strong\u003e Fold change in contact frequency of AR-bound enhancers looping to maximally expressed genes for H3K27ac (E+AR; blue) and H3K4me3 (E+AR; green) HiChIP. These CREs were compared to AR-free enhancers of highly expressed genes (E-ARi; black) in both HiChIP datasets.\u003c/p\u003e","description":"","filename":"4.jpg","url":"https://assets-eu.researchsquare.com/files/rs-3854707/v1/af7c634af667d7368ee5df1b.jpg"},{"id":50570151,"identity":"31bb7089-429d-435d-b1e8-d2e48568a81e","added_by":"auto","created_at":"2024-02-02 15:43:42","extension":"jpg","order_by":5,"title":"Figure 5","display":"","copyAsset":false,"role":"figure","size":1476529,"visible":true,"origin":"","legend":"\u003cp\u003eMulti-enhancer contact is strongly influenced by a dominant loop\u003cstrong\u003e (A) \u003c/strong\u003eSchematic representation of tested multi-enhancer models. Average model (left) represents equal impact of CREs (surrounding nodes; grey) on gene promoter (center node; black). Maximum model (middle) represents only one neighbor (unbroken line) impact on gene promoter (center node; black). Summation model (right) accept the variability (different width of blue/green arrows) and represents all CREs impact additively with their contact frequency to gene promoter. \u003cstrong\u003e(B) \u003c/strong\u003eScatter plot of binned (k=25) log expression (x-axis) vs. contact frequency (y-axis) according to the proposed multi-enhancer models function (16h HiChIP). Correlation was calculated by linear regression. \u003cstrong\u003e(C) \u003c/strong\u003eStandard deviation of H3K27ac and H3K4me3 HiChIP contact frequency change over time for dominant AR-bound CREs (D+) and non-dominant AR-bound CREs (D-) that interact with promoters of AR-regulated genes.\u003cstrong\u003e (D)\u003c/strong\u003e Schematic representation of hypothesized multi-enhancer dominance model. The width of arrows (blue/green) represent the contact frequency. \u003cstrong\u003e(E) \u003c/strong\u003eCircle plot representation of first-degree regulatory interactions of \u003cem\u003eKLK2\u003c/em\u003e (top) and \u003cem\u003eKLK3\u003c/em\u003e (bottom) genes. Promoters are shown in the centre (red) and the first-degree interactions are either AR-bound (yellow) or AR-free (greys) CREs. The size of the nodes represents the AR ChIP-seq signal, and the width of the edges represents contact frequency (H3K27ac CF: blue, H3K4me3 CF: green). \u0026nbsp;For all data ns p\u0026gt;0.05, * p\u0026lt;0.05, ** p\u0026lt;0.01, *** p\u0026lt;0.001, **** p\u0026lt;0.0001.\u003c/p\u003e","description":"","filename":"5.jpg","url":"https://assets-eu.researchsquare.com/files/rs-3854707/v1/4f0585f35ff30f2e2067c9bb.jpg"},{"id":50569863,"identity":"de4c2fd5-4b24-4c20-a547-c0e0ed1dd8e6","added_by":"auto","created_at":"2024-02-02 15:35:42","extension":"jpg","order_by":6,"title":"Figure 6","display":"","copyAsset":false,"role":"figure","size":562482,"visible":true,"origin":"","legend":"\u003cp\u003eAndrogen induced gene expression is significantly affected by perturbing the most dominant AR-bound enhancers.\u003cstrong\u003e (A) \u003c/strong\u003eFunctional characterization of individual AR-bound CRE on androgen-induced expression. Heatmap of contact frequency strength at each time point (H3K27ac: blue, H3K4me3: green) for individual AR-bound CREs to a target gene promoter (\u003cem\u003eKLK2, KLK3, NKX3-1, UAP1, ABCC4 \u003c/em\u003eand \u003cem\u003eDHCR24\u003c/em\u003e). Each AR-binding site (ARBS) was individually inhibited with CRISPRi and treated with androgen (10nM DHT). The inhibition of the target gene induction was calculated compared to the non-targeting control (CRISPRi FC Ci/NT; red). Identified dominant enhancers according to contact frequency are represented with red arrow. \u003cstrong\u003e(B) \u003c/strong\u003eCorrelation of CRISPRi induced gene-knockdown and chromatin loop dynamic (Standard Deviation in time) contact frequency for each ARBS. For all data ns p\u0026gt;0.05, * p\u0026lt;0.05, ** p\u0026lt;0.01, *** p\u0026lt;0.001, **** p\u0026lt;0.0001.\u003c/p\u003e","description":"","filename":"6.jpg","url":"https://assets-eu.researchsquare.com/files/rs-3854707/v1/b97feba5efdff3d1d0d8cff7.jpg"},{"id":68105277,"identity":"57f2dda4-4f53-43cb-9bc5-7a857b169796","added_by":"auto","created_at":"2024-11-03 08:06:41","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":6812800,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-3854707/v1/bfa8febc-2a11-484a-b8cd-740bb6998cf8.pdf"},{"id":50569868,"identity":"2cb62088-b96f-4e0e-bd6f-dd85bf177112","added_by":"auto","created_at":"2024-02-02 15:35:42","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":5805438,"visible":true,"origin":"","legend":"","description":"","filename":"SuppFigs.pdf","url":"https://assets-eu.researchsquare.com/files/rs-3854707/v1/fc3c68cf80c3ee9d9acad5d7.pdf"},{"id":50569866,"identity":"ab1ac33e-c504-4d42-852c-5c6bbea72592","added_by":"auto","created_at":"2024-02-02 15:35:42","extension":"pdf","order_by":2,"title":"","display":"","copyAsset":false,"role":"supplement","size":32755,"visible":true,"origin":"","legend":"","description":"","filename":"ARtranscriptionSuppTable1.pdf","url":"https://assets-eu.researchsquare.com/files/rs-3854707/v1/c51d1aba1c35f24c77beeb1f.pdf"},{"id":50570153,"identity":"c532801a-7b18-4a6c-bb68-d0fc8e71dcbe","added_by":"auto","created_at":"2024-02-02 15:43:42","extension":"pdf","order_by":3,"title":"","display":"","copyAsset":false,"role":"supplement","size":341458,"visible":true,"origin":"","legend":"","description":"","filename":"ARtranscriptionSuppTable2.pdf","url":"https://assets-eu.researchsquare.com/files/rs-3854707/v1/142d2c06976e629dd65da020.pdf"}],"financialInterests":"There is \u003cb\u003eNO\u003c/b\u003e Competing Interest.","formattedTitle":"Decoding the Epigenetics and Chromatin Loop Dynamics of Androgen Receptor-Mediated Transcription","fulltext":[{"header":"INTRODUCTION","content":"\u003cp\u003eThe androgen receptor (AR) is a ligand-dependent transcription factor that plays a critical role in regulating gene expression in the prostate\u003csup\u003e1\u003c/sup\u003e. In its inactive form, the AR resides in the cytoplasm where it is stabilized by heat-shock chaperone proteins\u003csup\u003e2\u003c/sup\u003e. After binding androgens, such as testosterone or dihydrotestosterone (DHT), the AR undergoes an allosteric modification and translocates into the nucleus\u003csup\u003e2\u0026ndash;4\u003c/sup\u003e. Once there, the AR binds to specific cis-regulatory elements (CREs) on DNA through an interplay of chromatin accessibility, pioneer factors such as FOXA1, and sequence motifs\u003csup\u003e5\u0026ndash;9\u003c/sup\u003e. The majority of these AR-bound CREs are proposed to function as enhancers as they are located distal from gene promoters\u003csup\u003e10\u003c/sup\u003e and are brought into close physical proximity by chromatin loops\u003csup\u003e11,12\u003c/sup\u003e. The enhancer activity at these CREs is associated with various epigenetic features, including chromatin accessibility, transcription factor binding, and post-translational histone modifications, such as H3K27ac and H3K4me3\u003csup\u003e13\u0026ndash;19\u003c/sup\u003e. CREs are proposed to impact transcription through chromatin contacts with the target promoter that cause the recruitment of co-regulatory proteins and transcriptional machinery\u003csup\u003e20\u0026ndash;23\u003c/sup\u003e. This typically involves multiple AR-bound enhancers and CREs that interact with the target promoter\u003csup\u003e24\u0026ndash;30\u003c/sup\u003e. The contribution of individual CREs has been controversial with some studies suggesting that CREs work additively to increase gene expression\u003csup\u003e31\u0026ndash;33\u003c/sup\u003e, while others propose that many enhancers are redundant and only contribute at specific developmental stages\u003csup\u003e34\u0026ndash;37\u003c/sup\u003e. The complex kinetic interplay of epigenetic modifications, co-regulatory proteins and chromatin loops across multiple CREs following transcription factor binding is poorly understood.\u003c/p\u003e \u003cp\u003eTo explore how AR binding impacts epigenetic modifications and chromatin looping at regulatory elements in response to an acute perturbation, we generated an extensive multi-omics experimental dataset following androgen stimulation that was integrated into a graph-based framework. We demonstrated that AR binding sequentially induces an increase in FOXA1 and H3K27ac signals, that was followed by an increase in chromatin accessibility. We further show that AR does not induce new chromatin loops, but instead increases the contact frequency between gene promoters and selective AR-bound enhancers. From these results, we generated and validated a multi-enhancer model, where a small subset of pre-established dominant CREs with increased chromatin contact frequency exhibits an elevated dynamic response to androgen stimulation, which significantly contribute to gene expression. These results provide a foundation for understanding how enhancers respond to an acute perturbation.\u003c/p\u003e"},{"header":"METHODS","content":"\u003cdiv id=\"Sec3\" class=\"Section2\"\u003e \u003ch2\u003eExperimental\u003c/h2\u003e \u003cdiv id=\"Sec4\" class=\"Section3\"\u003e \u003ch2\u003eLNCaP Cell culture and DHT treatment\u003c/h2\u003e \u003cp\u003eLNCaP cells (#CRL-1740, ATCC) were grown in phenol red-free RPMI (#11835030, GIBCO) with 10% charcoal-stripped FBS (#100\u0026ndash;119, GemBio) for 3 days and then were stimulated with 10nM dihydrotestosterone (DHT) (A8380, Sigma) for 0.5, 4, 16 or 72 hours. For the vehicle samples, the cells were treated with 100% EtOH. Subsequently, cells were collected for further experiments (ChIP-seq, RNA-seq, ATAC-seq, HiChIP, or Start-seq) accordingly\u003csup\u003e38\u003c/sup\u003e. LNCaP cells were authenticated by sequencing and comparing short tandem repeats to parental LNCaP cells in the ATCC database. Prior to experiments, cells were tested for mycoplasma contamination with LookOut Mycoplasma PCR Detection Kit (Sigma-Aldrich #D9307).\u003c/p\u003e \u003c/div\u003e \u003c/div\u003e \u003cdiv id=\"Sec5\" class=\"Section2\"\u003e \u003ch2\u003eChromatin Immunoprecipitation Assays with Sequencing (ChIP-seq)\u003c/h2\u003e \u003cp\u003eChIP-seq in LNCaP was performed as previously described\u003csup\u003e38\u003c/sup\u003e. Briefly, 10\u0026nbsp;million cells were fixed with 1% formaldehyde at room temperature for 10 min, quenched, and collected in lysis buffer (1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS and protease inhibitor [#11873580001, Roche] in PBS). Chromatin was sonicated with a Covaris E220 sonicator (140PIP, 5% duty cycle, 200 cycle burst). The sample was then incubated with antibodies (AR: Abcam ab133273, FOXA1: Abcam ab23738, H3K27ac: Diagenode 3C15410196; H3K4me3: Diagenode 3C15410003) coupled with Dynabeads protein A and protein G beads (Life Technologies) at 4 \u003csup\u003eo\u003c/sup\u003eC. Incubated chromatin was washed with RIPA wash buffer (100 mM Tris pH 7.5, 500 mM LiCl, 1% NP-40, 1% sodium deoxycholate) for 10 min six times and rinsed with TE buffer (pH 8.0) once. DNA was purified using a MinElute column followed by incubation in the de-crosslinking buffer (1% SDS, 0.1 M NaHCO3 with Proteinase K and RNase A) at 65 \u003csup\u003eo\u003c/sup\u003eC. Eluted DNA was prepared as sequencing libraries with the ThruPLEX-FD Prep Kit (Takara bio, # R400675). Libraries were sequenced with 150-BP PE on an Illumina HiSeq 2500 Sequencing platform at Novogene.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec6\" class=\"Section2\"\u003e \u003ch2\u003eRNA-Seq\u003c/h2\u003e \u003cp\u003eLNCaP cells (5x10^5) were harvested for RNA-seq\u003csup\u003e39\u003c/sup\u003e. Total RNA was collected from the cells using an RNeasy kit (Qiagen, #74104,) with DNase I treatment (Qiagen, #79254). The library preparations, quality control, and sequencing on HiSeq 2500 Sequencing platforms (150-BP PE) were performed by Novogene.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec7\" class=\"Section2\"\u003e \u003ch2\u003eAssay for transposase-accessible chromatin with sequencing (ATAC-seq)\u003c/h2\u003e \u003cp\u003eLNCaP cells were isolated and subjected to modified ATAC\u0026ndash;seq as previously described\u003csup\u003e38\u003c/sup\u003e. Briefly, 50,000 nuclei were pelleted and resuspended in ice-cold 50\u0026micro;l of lysis buffer (10 mM Tris-HCl, pH 7.5, 10mM NaCl, 3mM MgCl2, 0.1% NP-40, 0.1% Tween20, and 0.01% Digitonin). The subsequent centrifugation was performed at 500 g for 10 min at 4\u0026deg;C. The nuclei pellets were resuspended in 50\u0026micro;l of transposition buffer (25\u0026micro;l of 2\u0026times; TD buffer, 22.5\u0026micro;l of distilled water, 2.5 \u0026micro;l of Illumina Tn5 transposase) and incubated at 37\u0026deg;C for 30 min with shaking at 1000 rpm for fragmentation. Transposed DNA was purified with the MinElute PCR Purification kit (Qiagen). DNA was purified using Qiagen MinElute (#28004), and the library was amplified up to the cycle number determined by 1/3rd maximal qPCR fluorescence. ATAC-seq libraries were sequenced with 150-BP PE high-throughput sequencing on an Illumina HiSeq 2500 Sequencing platform (Novogene).\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec8\" class=\"Section2\"\u003e \u003ch2\u003eHiC combined with capture ChIP-seq (HiChIP)\u003c/h2\u003e \u003cp\u003eHiChIP was performed as previously described\u003csup\u003e39\u003c/sup\u003e. Trypsinized LNCaP cells (10\u0026nbsp;million) were fixed with 1% formaldehyde at room temperature for 10 min and quenched. The sample was lysed in HiChIP lysis buffer and digested with MboI (NEB) for 4 h. After 1 h of biotin incorporation with biotin dATP, the sample was ligated with T4 DNA ligase for 4 h with rotation. Chromatin was sonicated using Covaris E220 (conditions: 140 PIP, 5% DF, 200 CB) to 300\u0026ndash;800 bp in ChIP lysis buffer (1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS and protease inhibitor in PBS) and centrifuged at 13,000 rpm. for 10 minutes at 4\u0026deg;C. Preclearing 30\u0026micro;l of Dynabeads protein A/G for 1 h at 4\u0026deg;C was followed by incubation with antibodies (H3K27ac, Diagenode, 3C15410196; H3K4me3, Diagenode 3C15410003). Reverse-crossed IP sample were pulled down with streptavidin C1 beads (Life Technologies), treated with Transposase (Illumina) and amplified with reasonable cycle numbers based on the qPCR with a 5-cycle pre-amplified library. The library was sequenced with 150-BP PE reads on the Illumina HiSeq 2500 Sequencing platform (Novogene).\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec9\" class=\"Section2\"\u003e \u003ch2\u003eSmall Capped Nascent RNA Sequencing (Start-seq)\u003c/h2\u003e \u003cp\u003eFor Start-seq, LNCaP cells were grown and collected as described as above. Cell pellets were washed with ice-cold 1x PBS. 1\u0026nbsp;million cells were treated with 1.5mL of Nun Buffer (0.3M NaCl, 1M Urea, 1% NP-40, 20mM HEPES pH 7.5, 7.5mM MgCl2, 0.2M EDTAm, protease inhibitors and 20U/mL SUPERase-IN) for 30 min on ice with frequent vortexing. Chromatin was pelleted by centrifugation at 12500 g for 30 min for 4\u0026deg;C. After 3 times-washing with 1mL ice-cold chromatin washing buffer (50mM Tris-HCL pH7.5 and 40U/mL SUPERase-In) and additional 0.5mL of Nun buffer. After centrifugation for 5 min at 500 g, 0.5m TRIzol was added to the remaining pellet. Libraries were prepared according to the TruSeq Small RNA Kit (Illumina). To normalize samples, 15 synthetic capped RNAs were spiked into the Trizolpreparation at a specific quantity per 10^7 cells, as in\u003csup\u003e40\u003c/sup\u003e. The library was sequenced with 150-BP PE reads on the Illumina HiSeq 2500 Sequencing platform (Novogene).\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec10\" class=\"Section2\"\u003e \u003ch2\u003eCRISPRi\u003c/h2\u003e \u003cp\u003eGuide RNAs (gRNAs) were designed for each enhancer and promoter region using CRISPR-SURF\u003csup\u003e41\u003c/sup\u003e. Cas-OFFinder was used to eliminate off-target gRNAs\u003csup\u003e42\u003c/sup\u003e. LNCaP cells stably expressing dCas9-KRAB (Addgene #89567) were seeded in a 6-well plate at a density of 200K cells per well. For transfection, a total of 500-1500ng DNA was used, divided according to the number of available gRNAs. Transfection was performed using Mirus TransIT-X2. After transfection, the media was replaced and 2ng/\u0026micro;l of puromycin was added for selection. Following 72 h of selection, the medium was changed to charcoal-stripped serum for androgen deprivation. After 48 h, the cells were treated with 10nM DHT for 4 h and then trypsinized. RNA extraction and cDNA preparation was performed using the LunaScript\u0026reg; RT SuperMix Kit. The androgen-induced expression was quantified using qRT-PCR and each experiment was conducted in triplicate. The sequences of gRNAs and qRT-PCR primers can be found in \u003cb\u003eSupp Table\u0026nbsp;1\u003c/b\u003e.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec11\" class=\"Section2\"\u003e \u003ch2\u003eBioinformatics Analyses\u003c/h2\u003e \u003cdiv id=\"Sec12\" class=\"Section3\"\u003e \u003ch2\u003eRNA-seq analysis\u003c/h2\u003e \u003cp\u003eReads were aligned to the hg19 human genome with STAR (v2.7.9)\u003csup\u003e43\u003c/sup\u003e with quant mode (--quantMode TranscriptomeSAM). Next, \u0026ldquo;toTranscriptome\u0026rdquo; bam files were fed into Salmon (v0.14.1)\u003csup\u003e44\u003c/sup\u003e to quantify TPM values for (Gencode v19)\u003csup\u003e45\u003c/sup\u003e transcripts. To generate the signal track files from RNA-seq, VIPER\u003csup\u003e46\u003c/sup\u003e is used. Briefly, STAR as the default aligner, converts BAM files into BigWig files using Bedtools (v2.30.0)\u003csup\u003e47\u003c/sup\u003e.\u003c/p\u003e \u003c/div\u003e \u003c/div\u003e \u003cdiv id=\"Sec13\" class=\"Section2\"\u003e \u003ch2\u003eChIP-seq and ATAC-seq analyses\u003c/h2\u003e \u003cp\u003eChIP-seq and ATAC-seq were processed through the ChiLin pipeline\u003csup\u003e48\u003c/sup\u003e. Briefly, Illumina Casava1.7 software used for base calling and raw sequence quality and GC content were checked using FastQC (v0.10.1). The Burrows\u0026ndash;Wheeler Aligner (BWA\u003csup\u003e49\u003c/sup\u003e, v0.7.10) was used to align the reads to the human genome hg19. Then, MACS2\u003csup\u003e50\u003c/sup\u003e (v2.1.0.20140616) was used for peak calling with an FDR q-value threshold of 0.01. Bed files and Bigwig files were generated using bedGraphToBigWig\u003csup\u003e51\u003c/sup\u003e and the union of narrow and broad peaks from ChIP-seq were used as anchors to call loops. The following quality metrics were assessed for each sample: (i) percentage of uniquely mapped reads, (ii) PCR bottleneck coefficient to identify potential over-amplification by PCR, (iii) FRiP (fraction of non-mitochondrial reads in peak regions), (iv) peak number, (v) number of peaks with 10-fold and 20-fold enrichment over the background, (vi) fragment size, (vii) the percentage of the merged peaks with promoter, enhancer, intron, or intergenic, and (viii) peak overlap with DNaseI hypersensitivity sites. For datasets with replicates, the replicate consistency was checked by two metrics: 1. Pearson correlation of reads across the genome using UCSC software wigCorrelate after normalizing signal to reads per million and 2. percentage of overlapping peaks in the replicates.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec14\" class=\"Section2\"\u003e \u003ch2\u003eHiChIP Loop calling\u003c/h2\u003e \u003cp\u003eAfter trimming adaptors from the HiChIP datasets using Trim Galore (v0.5.0) (\u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://github.com/FelixKrueger/TrimGalore\u003c/span\u003e\u003cspan address=\"https://github.com/FelixKrueger/TrimGalore\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e), we used HiC-Pro (v3.1.0)\u003csup\u003e52\u003c/sup\u003e as previously described in Giambartolomei and Seo \u003cem\u003eet al.\u003c/em\u003e\u003csup\u003e39\u003c/sup\u003e. This aligned the reads to the hg19 human genome, assigned reads to MboI restriction fragments, and removed duplicate reads. We used the following options: \u0026lt;MIN_MAPQ\u0026thinsp;=\u0026thinsp;20, BOWTIE2_GLOBAL_OPTIONS = \u0026ndash;very-sensitive\u0026ndash;end-to-end\u0026ndash;reorder, BOWTIE2_LOCAL_OPTIONS = \u0026ndash;very-sensitive\u0026ndash;end-to-end\u0026ndash;reorder, GENOME_FRAGMENT\u0026thinsp;=\u0026thinsp;MboI_resfrag_hg19.bed, LIGATION_SITE\u0026thinsp;=\u0026thinsp;GATCGATC, LIGATION_SITE = \u0026ldquo;GATCGATC,\u0026rdquo; BIN_SIZE = \u0026ldquo;5000.\u0026rdquo;\u0026gt; All other default settings were used. To build the contact maps, the HiC-Pro pipeline selects only uniquely mapped valid read pairs involving two different restriction fragments. We applied FitHiChIP (v10.0)\u003csup\u003e53\u003c/sup\u003e for bias-corrected peak and DNA loop calls. FitHiChIP models the genomic distance effect with a spline fit, normalizes for coverage differences with regression, and computes statistical significance estimates for each pair of loci. We used the FitHiChIP loop significance model to determine whether interactions are significantly stronger than the random background interaction frequency. As anchors to call loops in the HiChIP analyses, we used 842367 regions for H3K27ac and 136939 regions for H3K4me3, which resulted from merging ChIP-seq narrow and broad peaks comprised 2 replicates for each broad and narrow peak and each of the five-time points (0m, 30m, 4h, 16h, 72h) for H3K27ac, and 1 replicate for each broad and narrow peak and each of the same time points for H3K4me3. We used a 5 kb resolution and considered only interactions between 5 kb and 3 Mb. We used the peak to all for the foreground, meaning at least one anchor needed to be in the peak rather than both. The corresponding FitHiChIP options specification is \u0026lt;\u0026thinsp;IntType\u0026thinsp;=\u0026thinsp;3\u0026thinsp;\u0026gt;\u0026thinsp;For the global background estimation of expected counts (and contact probabilities for each genomic distance), FitHiChIP can use either peak-to-peak (stringent) or peak-to-all (loose) loops for learning the background and spline fitting. We specified the suggested option to merge interactions close to each other to represent a single interaction when their originating bins are closer. The corresponding FitHiChIP options specifications are \u0026lt;\u0026thinsp;UseP2PBackgrnd\u0026thinsp;=\u0026thinsp;0\u0026thinsp;\u0026gt;\u0026thinsp;and \u0026lt;\u0026thinsp;MergeInt\u0026thinsp;=\u0026thinsp;1\u0026gt; (FitHiChIP (L\u0026thinsp;+\u0026thinsp;M)). We used the default FitHiChIP q value\u0026thinsp;\u0026lt;\u0026thinsp;0.01 to identify significant loops. We used hicpro2higlass (v3.1.0) to convert allValidPairs to .cool files after having specified the hg19 chromosome sizes, using the following command: \u0026lt;hicpro2higlass.sh -i sample.allValidPairs -r 5000 -c chrsizes -n\u0026thinsp;\u0026gt;\u0026thinsp;The reads from HiChIP data were merged from every time point for H3K27ac and H3K4me3 separately, and the reference loop sets were called with the same parameters above (resulting loop number, n\u0026thinsp;=\u0026thinsp;296,326; n\u0026thinsp;=\u0026thinsp;278,491 respectively). Next, the contact frequency values of each time point at loops are captured from the .cool files using the Python package, Cooler (v0.9.3). The count table was then TMM normalized among time points to reduce the between-sample variation.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec15\" class=\"Section2\"\u003e \u003ch2\u003eAnnotation of Cis-Regulatory Elements / Defining Background Genes\u003c/h2\u003e \u003cp\u003eCREs were defined as +/- 2.5 kb around the summit of the accessible region from ATAC-seq peaks at any given time point. Promoters were defined with a multi-step process. First, we identified the highest expression transcript (Gencode v19)\u003csup\u003e45\u003c/sup\u003e isoforms using Salmon (v0.14.1)\u003csup\u003e44\u003c/sup\u003e, see RNA-seq analysis. Next, the start locations -according to strand information- of the highest expressing transcripts were collected and the summit was extended +/2.5 kb. If they overlap with a defined CRE, we assigned the overlapping CRE as the active promoters. From these annotated active promoters, the genes of HALLMARKS_ANDROGEN_RESPONSE from the Molecular Signature Database (MSigDB)\u003csup\u003e54\u003c/sup\u003e were defined as AR-regulated genes. The transcriptome was divided into four quartiles and AR-regulated genes were compared with similarly expressing genes (\u003cb\u003eSupp Fig.\u0026nbsp;1A, B\u003c/b\u003e). Overlapping CREs to an AR ChIP-seq peaks at any time point were defined as potential AR-bound enhancers. The median number AR-bound enhancers (E\u0026thinsp;+\u0026thinsp;AR; ~2) of AR-regulated genes were less than AR-free enhancers (E-AR; ~14) (\u003cb\u003eSupp Fig.\u0026nbsp;1E\u003c/b\u003e). Similarly, a CRE was considered FOXA1-bound, if it intersects with a FOXA1 peak at any time point (\u003cb\u003eSupp Fig.\u0026nbsp;1C\u003c/b\u003e). To identify down-regulated genes, we calculated the log2foldChange induction between 16h and 0m, considering those with a value below \u0026minus;\u0026thinsp;1 as downregulated genes (\u003cb\u003eSupp Fig.\u0026nbsp;3A, B\u003c/b\u003e).\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec16\" class=\"Section2\"\u003e \u003ch2\u003eConstructing the Graph Network\u003c/h2\u003e \u003cp\u003eWhen we called significant loops from each time point separately, there were few called loops overlapping between time points potentially due to both the loop calling methodologies and experimental noise present in HiChIP data\u003csup\u003e55\u003c/sup\u003e. As we could observe the matching loops in the contact matrices of all time points (\u003cb\u003eSupp Fig.\u0026nbsp;5\u003c/b\u003e), we instead generated a reference loop set, normalized the count matrix, and compared contact frequencies similar to published work\u003csup\u003e20\u003c/sup\u003e. A custom R (v4.1.1) script (\u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://github.com/lacklab/AR_transcription\u003c/span\u003e\u003cspan address=\"https://github.com/lacklab/AR_transcription\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e) was used to extract interaction pairs of annotated CRE regions (BED) according to the reference loop set (BEDPE; both H3K27ac and H3K4me3) using `GenomicInteractions` (v1.34)\u003csup\u003e56\u003c/sup\u003e. The graph structure is built in custom Python (v3.9.7) script (link) using the NetworkX (v3.1) package\u003csup\u003e57\u003c/sup\u003e. Briefly, any pair of CREs are included as nodes in the network with TMM normalized HiChIP contact frequency as weighted edges, for both H3K27ac and H3K4me3 at every time point.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec17\" class=\"Section2\"\u003e \u003ch2\u003eEpigenetic changes of CREs and kinetic changes of enhancers of AR-regulated genes\u003c/h2\u003e \u003cp\u003eThe average signal (AR, FOXA1, H3K27ac, H3K4me3, ATAC) at the promoters and CREs were collected using a custom python package (\u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://github.com/breambio/bluegill\u003c/span\u003e\u003cspan address=\"https://github.com/breambio/bluegill\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e). To reduce the batch effect across time, TMM normalization was applied individually for each epigenetic factor\u003csup\u003e58\u003c/sup\u003e. To visualize the temporal change upon androgen stimulation, line plots were drawn (\u003cb\u003eFig.\u0026nbsp;2\u003c/b\u003e). For the selected six AR-regulated genes (\u003cb\u003eFig.\u0026nbsp;3F\u003c/b\u003e), both the average signal (AR, FOXA1, H3K27ac, H3K4me3, ATAC) over the first-degree interacting enhancers of each gene promoter and contact frequency (CF) between every gene promoter and corresponding enhancer were collected for every time point. The standard deviation (SD) of each feature along the time domain was calculated and min-max normalized.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec18\" class=\"Section2\"\u003e \u003ch2\u003eCalculation of chromatin contact frequency change\u003c/h2\u003e \u003cp\u003ePromoter-centric analysis was done with the query loop sets, AR-regulated genes\u0026rsquo; promoter loops (P\u0026thinsp;+\u0026thinsp;AR), and random highly expressed genes\u0026rsquo; promoter loops (P-AR; n\u0026thinsp;=\u0026thinsp;100 ; seed\u0026thinsp;=\u0026thinsp;7). This was compared to reference loop sets (n\u0026thinsp;=\u0026thinsp;100) that was randomized (1000 iterations; seed\u0026thinsp;=\u0026thinsp;7) from highly expressed genes\u0026rsquo; promoter loops (\u003cb\u003eFig.\u0026nbsp;3B\u003c/b\u003e). Fold change was calculated for each iteration between the average contact frequency of loops in the query and reference. The same approach was used to calculate the contact frequency fold change from the enhancer viewpoint. The loop sets were selected according to the E-P pairs. While selecting the query and reference loops, the number of randomly selected promoters was fixed (n\u0026thinsp;=\u0026thinsp;100). The loops between AR-regulated gene promoters to AR-bound (E\u0026thinsp;+\u0026thinsp;AR) and AR-free enhancers (E-AR), and between AR-independent gene promoters to AR-free enhancers (E-AR) were compared to randomized loops from an AR-free enhancer to highly expressed gene promoters (1000 iterations; seed\u0026thinsp;=\u0026thinsp;7).\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec19\" class=\"Section2\"\u003e \u003ch2\u003eStart-seq analysis\u003c/h2\u003e \u003cp\u003eAdaptor sequences and low-quality 3\u0026prime; ends were removed from paired-end reads of all samples using cutadapt (v1.2.1). Reads shorter than 20 nucleotides were discarded (-m 20 -q 10), and a single nucleotide was trimmed from the 3\u0026prime; end of all remaining reads to enable successful alignment with bowtie (v1.1.1). The first in pair flagged reads were filtered to generate signal (bigwig) files for each strand using bedtools genomecov (-bg -5 -strand +/-, respectively).\u003c/p\u003e \u003cp\u003eThe transcripts (Gencode v19) were extracted GTF file. The maximum signal within a range of +/- 500 bp of TSS was gathered from the forward Start-seq track for plus-stranded transcripts, and the reverse for minus-stranded transcripts. Next, the log2foldchange (LFC), compared to 0m, was calculated for every time point (30m, 4h, 16h, 72h). If a transcript was found to be LFC\u0026thinsp;\u0026gt;\u0026thinsp;1 at any time point, it was considered as differential up regulation. Next, the nascent expression levels at all time points for those transcripts (the union of differential up-regulation) were z-normalized to capture the highest expression time point, which is assigned to time-based expression groups (\u003cb\u003eFig.\u0026nbsp;4A\u003c/b\u003e). Similar to enhancer viewpoint analysis, the first-degree AR-bound enhancer contact frequency to the gene promoters was compared to randomly selected contact frequencies (1000 iterations) between the highly expressed gene promoters (n\u0026thinsp;=\u0026thinsp;100) and their first-degree AR-free enhancers.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec20\" class=\"Section2\"\u003e \u003ch2\u003eContact frequency, expression correlation\u003c/h2\u003e \u003cp\u003eTo explore the contact frequency vs. expression, we performed three first-degree summarization models (average, maximum, and sum). Briefly, we identified all first-degree contacts of every gene promoter, then we summarized the contact frequencies with the corresponding function of the models for every gene. To reduce the signal noise, we first sorted genes according to expression, binned them into equal-sized sets (k\u0026thinsp;=\u0026thinsp;25), plotted bins as a scatter plot with average log expression on the x-axis, and averaged summarized contact frequency on the y-axis (\u003cb\u003eFig.\u0026nbsp;5B, Supp Fig.\u0026nbsp;7\u003c/b\u003e).\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec21\" class=\"Section2\"\u003e \u003ch2\u003eRandom Forest Regressor\u003c/h2\u003e \u003cp\u003eThe binned (k\u0026thinsp;=\u0026thinsp;25) contact frequency and expression data (see above) were used to train a random forest regressor from the Sklearn (v1.3.1)\u003csup\u003e59\u003c/sup\u003e with \u0026ldquo;random_state\u0026thinsp;=\u0026thinsp;0\u0026rdquo;. The permutation importance of each feature is also calculated within the Sklearn\u003csup\u003e60\u003c/sup\u003e.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec22\" class=\"Section2\"\u003e \u003ch2\u003eGini Index Analysis\u003c/h2\u003e \u003cp\u003eThe chromatin contact frequency between gene promoter and first-degree interacting elements was identified and the Gini index was calculated for a 16h time-point (\u003cb\u003eFig.\u0026nbsp;5C\u003c/b\u003e). To calculate the Gini index a custom python function was utilized (\u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://github.com/lacklab/AR_transcription\u003c/span\u003e\u003cspan address=\"https://github.com/lacklab/AR_transcription\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e). The mean absolute difference is the average absolute difference between all pairs of items in the population. The relative mean absolute difference is obtained by dividing the mean absolute difference by the population's average (\u003cspan class=\"InlineEquation\"\u003e\u003cspan class=\"mathinline\"\u003e\\(\\overline{x}\\)\u003c/span\u003e\u003c/span\u003e) to account for differences in scale (e.q 1), where \u003cspan class=\"InlineEquation\"\u003e\u003cspan class=\"mathinline\"\u003e\\({x}_{i}\\)\u003c/span\u003e\u003c/span\u003e is contact frequency of a loop \u003cem\u003ei\u003c/em\u003e, and there are \u003cem\u003en\u003c/em\u003e loops of a promoter.\u003cdiv id=\"Equa\" class=\"Equation\"\u003e\u003cdiv format=\"TEX\" class=\"mathdisplay\" id=\"FileID_Equa\" name=\"EquationSource\"\u003e\n$$G= \\frac{\\sum _{i=1}^{n}\\sum _{j=1}^{n}\\left|{x}_{i}-{x}_{j}\\right|}{2{n}^{2}\\overline{x}}$$\u003c/div\u003e\u003c/div\u003e\u003c/p\u003e \u003cdiv id=\"Sec23\" class=\"Section3\"\u003e \u003ch2\u003eCircle Plots\u003c/h2\u003e \u003cp\u003eCircle plots were drawn with NetworkX and Matplotlib libraries\u003csup\u003e57,61\u003c/sup\u003e (\u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://github.com/lacklab/AR_transcription\u003c/span\u003e\u003cspan address=\"https://github.com/lacklab/AR_transcription\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e).\u003c/p\u003e \u003c/div\u003e \u003c/div\u003e \u003cdiv id=\"Sec24\" class=\"Section2\"\u003e \u003ch2\u003eStatistical analysis\u003c/h2\u003e \u003cp\u003eThe probability of finding \u003cem\u003ek\u003c/em\u003e loops from each CREs was determined by hypergeometric distribution (\u003cb\u003eSupp Fig.\u0026nbsp;4\u003c/b\u003e). When comparing the target set with the background set, a non-parametric Mann-Whitney-U test was applied. Correlation coefficients and their p-values were calculated with Spearman\u0026rsquo;s test. All statistical tests were performed using the SciPy (v1.11.1) Python package\u003csup\u003e62\u003c/sup\u003e.\u003c/p\u003e \u003c/div\u003e"},{"header":"RESULTS","content":"\u003cdiv id=\"Sec26\" class=\"Section2\"\u003e\n\u003ch2\u003eGeneration of androgen-stimulation kinetic dataset and construction of regulatory networks\u003c/h2\u003e\n\u003cp\u003eTo characterize the temporal impact of AR binding on epigenetic features and chromatin looping, we generated an extensive kinetic multi-omics experimental dataset following androgen stimulation. We treated LNCaP cells with dihydrotestosterone and collected cells at 5 different time points (0m, 30m, 4h, 16h, 72h). At each time point, multiple features were characterized including gene expression (RNA-seq), chromatin accessibility (ATAC-seq), transcription factor binding and post-translational histone modification (AR, FOXA1, H3K27ac and H3K4me3 ChIP-seq), chromatin looping (HiChIP) and capped nascent RNA (Start-seq) (\u003cstrong\u003eFig.\u0026nbsp;1A\u003c/strong\u003e). From these datasets, CREs (n\u0026thinsp;=\u0026thinsp;78,522) were defined from accessible sites (ATAC-seq)\u003csup\u003e15\u003c/sup\u003e. Based on known gene annotations and AR ChIP-seq, CREs were annotated as either promoters (n\u0026thinsp;=\u0026thinsp;13,575), AR-free CREs (n\u0026thinsp;=\u0026thinsp;58,265), or AR-bound CREs (n\u0026thinsp;=\u0026thinsp;6,682). The interaction between these CREs was defined from consensus H3K27ac (enhancer-centric; n\u0026thinsp;=\u0026thinsp;296,326) and H3K4me3 (promoter-centric; n\u0026thinsp;=\u0026thinsp;278,491; see methods) HiChIP loop sets. Supporting that these histone marks are associated with different functional CREs, only 23% of loops were found in both H3K27ac and H3K4me3 HiChIP (\u003cstrong\u003eFig.\u0026nbsp;1B\u003c/strong\u003e). As expected, H3K27ac loops were predominantly between enhancer-enhancer (E-E) pairs, accounting for 43.2% of the loops, followed by enhancer-promoter (E-P) pairs, which constituted around 40.4% (\u003cstrong\u003eFig.\u0026nbsp;1C\u003c/strong\u003e). In contrast, H3K4me3 loops were primarily between E-P pairs, making up 58.8% of the total loops. This is consistent with the known associations of these histone marks to promoter and enhancer CREs\u003csup\u003e63\u0026ndash;65\u003c/sup\u003e. To allow more quantitative analyses of these large-scale chromatin interactions we transformed the resulting HiChIP looping data into a graphical network with each node representing a CRE and the edges being the chromatin loops between these two elements (\u003cstrong\u003eFig.\u0026nbsp;1D\u003c/strong\u003e). With this regulatory network, we then overlaid the various multi-omics datasets to provide a framework that can interrogate the impact of AR binding. We investigated androgen-driven AR-mediated gene transcription based on the previously characterized hallmark androgen-responsive genes (\u003cstrong\u003eSupp Fig.\u0026nbsp;1A, B\u003c/strong\u003e). As expected, these were induced compared to similarly expressed random AR-independent genes (\u003cstrong\u003eFig.\u0026nbsp;1E\u003c/strong\u003e). This comprehensive multi-omics dataset and graphical regulatory network provided a framework to quantitatively investigate the temporal impact of AR binding on epigenetic features, chromatin looping, and gene expression.\u003c/p\u003e\n\u003cdiv id=\"Sec27\" class=\"Section3\"\u003e\n\u003ch2\u003eAndrogen stimulation leads to stepwise epigenetic changes\u003c/h2\u003e\n\u003cp\u003eWith this structured regulatory network, we then explored how AR binding affects each epigenetic feature and its relationship with gene transcription. The AR-regulated genes\u0026rsquo; promoters (P\u0026thinsp;+\u0026thinsp;AR) and their looped AR-bound enhancers (E\u0026thinsp;+\u0026thinsp;AR) were compared to randomly matched from highly expressed AR-independent genes\u0026rsquo; promoters (P-AR) and their looped AR-free enhancer (E-AR) (\u003cstrong\u003eFig.\u0026nbsp;2A\u003c/strong\u003e). We observed that E\u0026thinsp;+\u0026thinsp;AR displayed a strong AR and FOXA1 signal following androgen stimulation, that reached its peak at 4h and then subsequently decreased at 16h and 72h. Emphasizing FOXA1's pioneering activity, E\u0026thinsp;+\u0026thinsp;AR displayed elevated FOXA1 signal at the initial time point (0m). As expected, the AR and FOXA1 signal did not significantly change at AR-independent promoters or AR-free enhancer. Interestingly, those FOXA1-bound CREs that were not co-occupied by AR had no change in the relative FOXA1 signal (\u003cstrong\u003eSupp Fig.\u0026nbsp;1C, D\u003c/strong\u003e), suggesting that AR potentially influences FOXA1 occupancy\u003csup\u003e66\u003c/sup\u003e. As expected, we observed a higher H3K4me3 ChIP-seq signal at promoters compared to enhancers. This signal was largely unaffected by AR binding, but there were selective genes, including \u003cem\u003eKLK3\u003c/em\u003e, which exhibited an increasing H3K4me3 mark at its promoter following androgen treatment (\u003cstrong\u003eSupp Fig.\u0026nbsp;2\u003c/strong\u003e). We observed an elevated H3K27ac signal at promoters compared to enhancers (\u003cstrong\u003eFig.\u0026nbsp;2A\u003c/strong\u003e). Further, the H3K27ac signal increased specifically at E\u0026thinsp;+\u0026thinsp;AR, while it remained unchanged at E-AR. This change at E\u0026thinsp;+\u0026thinsp;AR was also observed for chromatin accessibility (ATAC-seq), though the maximum signal (16h) was found to occur after AR and FOXA1 peak occupancy (4h). We also investigated the epigenetic changes of AR down-regulated gene promoters and their AR-bound enhancers (\u003cstrong\u003eSupp Fig.\u0026nbsp;3A, B)\u003c/strong\u003e. Interestingly, we observed that the AR-bound CREs (E\u0026thinsp;+\u0026thinsp;dAR), that were looped to the promoter of down-regulated genes (P\u0026thinsp;+\u0026thinsp;dAR) displayed a very similar increase in AR, FOXA1, H3K27ac, and chromatin accessibility (\u003cstrong\u003eFig.\u0026nbsp;2B\u003c/strong\u003e). There was no statistically significant change at any time point in the AR-bound enhancers of either up or downregulated genes (\u003cem\u003ep\u0026thinsp;\u0026gt;\u0026thinsp;0.1\u003c/em\u003e). Overall, these kinetic datasets show that there is a sequential process that occurs following androgen stimulation where AR, FOXA1, and H3K27ac signals selectively increase at looped enhancers before inducing subsequent changes in chromatin accessibility.\u003c/p\u003e\n\u003c/div\u003e\n\u003c/div\u003e\n\u003cdiv id=\"Sec28\" class=\"Section2\"\u003e\n\u003ch2\u003eAR-bound enhancers increase contact frequency to AR-upregulated gene promoters\u003c/h2\u003e\n\u003cp\u003eWe first investigated how chromatin looping changed following AR activation. Initially, we compared the number of loops formed following androgen stimulation. We found that both promoters of AR-regulated genes (P\u0026thinsp;+\u0026thinsp;AR) and their looped AR-bound enhancers (E\u0026thinsp;+\u0026thinsp;AR) did not exhibit any significant changes (\u003cem\u003ep\u003c/em\u003e\u0026thinsp;\u0026gt;\u0026thinsp;0.05) in the number of loops compared to background P-AR/E-AR (\u003cstrong\u003eFig.\u0026nbsp;3A\u003c/strong\u003e). Supporting this, there was no significant difference in the distribution of the number of loops on gene promoters during androgen treatment (\u003cstrong\u003eSupp Fig.\u0026nbsp;4A\u003c/strong\u003e). These results demonstrate that AR binding does not cause a substantial rewiring of chromatin looping.\u003c/p\u003e\n\u003cp\u003eWhile androgen treatment did not significantly change the number of loops, we did observe an increase in contact frequency at AR-bound enhancers looped to AR-regulated genes (\u003cstrong\u003eSupp Fig.\u0026nbsp;5\u003c/strong\u003e). To quantify these changes, we calculated the fold change in contact frequency compared to bootstrapped (\u003cem\u003eb\u003c/em\u003e\u0026thinsp;=\u0026thinsp;1000) random AR-independent genes from both promoter and enhancer viewpoints (\u003cstrong\u003eFig.\u0026nbsp;3B\u003c/strong\u003e). We observed that AR activation increased the contact frequency of loops at AR-regulated promoters (P\u0026thinsp;+\u0026thinsp;AR) over time, with a peak at 16h (H3K27ac: \u003cem\u003ep\u003c/em\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.001; H3K4me3: \u003cem\u003ep\u003c/em\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.001) (\u003cstrong\u003eFig.\u0026nbsp;3C\u003c/strong\u003e). In contrast, the change in contact frequency of loops to promoters of AR independent genes (P-AR) remained stable. From an enhancer viewpoint (\u003cstrong\u003eFig.\u0026nbsp;3D\u003c/strong\u003e), AR-bound enhancer CREs (E\u0026thinsp;+\u0026thinsp;AR) showed a significant increase in both H3K27ac and H3K4me3 contact frequency (H3K27ac: \u003cem\u003ep\u003c/em\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.001; H3K4me3: \u003cem\u003ep\u003c/em\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.001). In contrast, AR-free CREs (E-AR; grey) that were connected to the same AR-regulated gene promoters did not exhibit any significant change. Further, no change in contact frequency was observed in the CREs (E-ARi; black) that interact with AR-independent gene promoters. While chromatin contact frequency increased between AR-bound enhancer CREs (E\u0026thinsp;+\u0026thinsp;AR) and upregulated hallmark gene promoters (P\u0026thinsp;+\u0026thinsp;AR), we did not observe any change in loops between AR-bound CREs (E\u0026thinsp;+\u0026thinsp;dAR) and downregulated gene promoters (\u003cstrong\u003eFig.\u0026nbsp;3E\u003c/strong\u003e). This is particularly striking as, AR-bound CREs (E\u0026thinsp;+\u0026thinsp;AR, E\u0026thinsp;+\u0026thinsp;dAR) exhibited a similar pattern in their epigenetic profiles, regardless of whether they looped to an upregulated or downregulated gene (\u003cstrong\u003eFig.\u0026nbsp;2A, Fig.\u0026nbsp;2B\u003c/strong\u003e). Given that a similar trend is observed at all AR-bound CREs, this suggests that epigenetic modifications must be combined with chromatin looping to contribute to gene expression.\u003c/p\u003e\n\u003cp\u003eTo interrogate the kinetic changes in epigenetics and contact frequency we focused on several up-regulated androgen-responsive genes (\u003cem\u003eKLK2\u003c/em\u003e, \u003cem\u003eKLK3\u003c/em\u003e, \u003cem\u003eNKX3-1\u003c/em\u003e, \u003cem\u003eUAP1\u003c/em\u003e, \u003cem\u003eABCC4\u003c/em\u003e, and \u003cem\u003eDHCR24\u003c/em\u003e) (\u003cstrong\u003eFig.\u0026nbsp;3F\u003c/strong\u003e). As expected, AR-free enhancers (E-AR; grey) had minimal changes in epigenetics and contact frequency. Interestingly, we observed that AR-bound enhancers (E\u0026thinsp;+\u0026thinsp;AR; orange) had broad heterogeneity in response to treatment. The same enhancer typically had both the highest change in epigenetic features and contact frequency. Our findings demonstrate that AR-bound enhancers increase contact frequency with AR-regulated gene promoters in response to androgen treatment. However, this response is heterogeneous and there is significant variability among AR-bound enhancers.\u003c/p\u003e\n\u003c/div\u003e\n\u003cdiv id=\"Sec29\" class=\"Section2\"\u003e\n\u003ch2\u003eAssociation of nascent transcription to epigenetic changes and contact frequency\u003c/h2\u003e\n\u003cp\u003eTo determine if the change in contact frequency precedes or occurs simultaneously with AR-mediated gene transcription, we characterized the kinetic rate of androgen-induced gene expression. We identified up-regulated androgen-induced genes from nascent RNA (Start-seq) and categorized them based on the maximal expression (30m, 4h, 16h or 72h) (\u003cstrong\u003eFig.\u0026nbsp;4A\u003c/strong\u003e). We chose to group these genes based on nascent RNA, as RNA-seq provides only steady-state quantification of mRNA transcripts\u003csup\u003e67\u003c/sup\u003e. Between these groups, no significant difference was observed in the maximal signal at AR-bound enhancers for AR, FOXA1 and H3K27ac ChIP-seq or chromatin accessibility (\u003cstrong\u003eFig.\u0026nbsp;4B\u003c/strong\u003e), suggesting that the epigenetic features do not dictate the timing of maximal nascent RNA production. However, we observed a temporal relationship between nascent transcription and chromatin contact frequency. Specifically, the maximal nascent transcription (4h and 16h groups) occurred simultaneously with an increase in H3K27ac and came before the peak of H3K4me3 (16h) maximal contact frequency at AR-bound enhancers (\u003cstrong\u003eFig.\u0026nbsp;4C\u003c/strong\u003e). These observations indicate that the change in contact frequency does not precede RNA transcription. Overall, these findings suggest that although AR and FOXA1 rapidly bind at enhancers upon androgen treatment, the maximal transcription occurs either simultaneously with or before a maximal alteration in chromatin contact frequency.\u003c/p\u003e\n\u003c/div\u003e\n\u003ch2\u003eMulti-enhancers influence transcription proportional to contact frequency\u003c/h2\u003e\n\u003cp\u003eHaving observed marked heterogeneity in chromatin loop contact frequency at AR-bound enhancers, we began to explore the impact of multi-enhancer contacts on gene expression. We expand the scale of our analysis across all detectable genes (n\u0026thinsp;=\u0026thinsp;13,575), and characterized how loop frequency correlates to gene expression. Most genes had multiple CREs interacting with target promoters with a median frequency of ~\u0026thinsp;15 interactions per gene (\u003cstrong\u003eSupp. Figure\u0026nbsp;6A\u003c/strong\u003e). With this large dataset, we evaluated three models correlating H3K27ac and H3K4me3 contact frequency to gene expression where: all interactions contribute equally to gene expression (average), only a single strong interaction affects gene expression (maximum) and all interactions contribute to gene expression in an additive manner (sum) (\u003cstrong\u003eFig.\u0026nbsp;5A\u003c/strong\u003e). While all models strongly correlated H3K27ac and H3K4me3 contact frequency to gene expression (\u003cem\u003ep\u003c/em\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.0001; Spearman\u0026rsquo;s test), we found that the sum model (H3K27ac; r\u0026thinsp;=\u0026thinsp;0.896, H3K4me3; r\u0026thinsp;=\u0026thinsp;0.904) and maximum model (H3K27ac; r\u0026thinsp;=\u0026thinsp;0.839, H3K4me3; r\u0026thinsp;=\u0026thinsp;0.876) correlated significantly better than the average model (H3K27ac; r\u0026thinsp;=\u0026thinsp;0.643, H3K4me3; r\u0026thinsp;=\u0026thinsp;0.679) across all time points (\u003cstrong\u003eFig.\u0026nbsp;5B and Supp Fig.\u0026nbsp;7\u003c/strong\u003e). To quantify the importance of each feature, we built a random forest regressor to predict the expression from these operations (Accuracy; r\u003csup\u003e2\u003c/sup\u003e\u0026thinsp;=\u0026thinsp;0.805) and found that the additive model (sum) best-predicted expression (\u003cstrong\u003eSupp Fig.\u0026nbsp;6B\u003c/strong\u003e)\u003csup\u003e68\u003c/sup\u003e. However, as we observed similar correlation with the maximum model, which scored only a single chromatin loop, this suggested that the contact frequency of chromatin loops to a promoter were markedly unbalanced and that there was a \u0026ldquo;dominant\u0026rdquo; interaction. To characterize this, we quantified the inequality of chromatin loop contact frequency to a target promoter and found that both H3K27ac and H3K4me3 were strongly unbalanced (\u003cem\u003eGini\u003c/em\u003e\u0026thinsp;\u0026gt;\u0026thinsp;~\u0026thinsp;0.5; \u003cstrong\u003eSupp Fig.\u0026nbsp;6C\u003c/strong\u003e). These findings suggest that enhancers interacting with gene promoters do not have a uniform distribution in contact frequency, and that there are \u0026ldquo;dominant\u0026rdquo; loops that strongly correlate with expression (\u003cstrong\u003eFig.\u0026nbsp;5D\u003c/strong\u003e).\u003c/p\u003e\n\u003cp\u003eTo better understand how these potential dominant loops are dynamically affected by acute perturbation, we characterized the CRE-promoter interactions of androgen-regulated genes (n\u0026thinsp;=\u0026thinsp;88; \u003cstrong\u003eSupp Table\u0026nbsp;2\u003c/strong\u003e). Dominant loops were identified for every gene promoter by first scaling the contact frequency of interacting CREs in the range (0, 1), and selecting the highest ones with a threshold (0.8). The dominant loops were not solely based on proximity to the gene promoter as they were the closest CRE in only 27% of AR-regulated genes (n\u0026thinsp;=\u0026thinsp;24) at any time point. Suggesting that the dominant loops are \u0026ldquo;primed\u0026rdquo; before AR binds, the same dominant loops were commonly found at every time point (\u003cstrong\u003eSupp Fig.\u0026nbsp;8\u003c/strong\u003e). Furthermore, we found that the dominant AR-bound CREs (D+) had significantly (p\u0026thinsp;\u0026lt;\u0026thinsp;0.0001) higher dynamic change in contact frequency than non-dominant AR-bound CREs (D-) that interacts with AR-regulated gene promoters (\u003cstrong\u003eFig.\u0026nbsp;5C\u003c/strong\u003e). Interestingly, the dominant loops were highly gene specific. When we characterized two AR-regulated genes, \u003cem\u003eKLK3\u003c/em\u003e and \u003cem\u003eKLK2\u003c/em\u003e, that share many looped CREs (\u003cstrong\u003eFig.\u0026nbsp;5E\u003c/strong\u003e), we observed gene-specific disparities in contact frequency changes from an AR enhancer (ARBS3) to either the \u003cem\u003eKLK2\u003c/em\u003e or \u003cem\u003eKLK3\u003c/em\u003e promoters. While ARBS3 displayed the strongest and most dynamic contact frequency with the \u003cem\u003eKLK2\u003c/em\u003e promoter, it did not exhibit the strongest change for the \u003cem\u003eKLK3\u003c/em\u003e promoter. Instead, the loop with well-known upstream AR-enhancer\u003csup\u003e69\u003c/sup\u003e (ARBS2) dominates others. Interestingly, both dominant loop enhancers were not the CRE with the highest change in AR peak height, suggesting that there are additional factors that contribute to changes in contact frequency. Overall, these results demonstrate that AR binding does not affect chromatin looping equally and that those CREs with the most dynamic contact frequency potentially have a greater impact on gene transcription.\u003c/p\u003e\n\u003cdiv id=\"Sec31\" class=\"Section2\"\u003e\n\u003ch2\u003eCRISPR-based perturbations confirm the existence of \u0026ldquo;dominant\u0026rdquo; chromatin loops\u003c/h2\u003e\n\u003cp\u003eTo experimentally validate these correlative models, we tested the effects of dominant chromatin loops on androgen-induced gene expression. Utilizing CRISPRi, a derivative of the CRISPR/Cas9 system that suppresses enhancer activity without altering DNA sequences, we inhibited all AR-bound enhancers (n\u0026thinsp;=\u0026thinsp;20) that interact with (\u003cstrong\u003eSupp Table\u0026nbsp;1, Supp Fig.\u0026nbsp;9\u003c/strong\u003e) the previously described AR-regulated genes (\u003cem\u003eKLK2\u003c/em\u003e, \u003cem\u003eKLK3\u003c/em\u003e, \u003cem\u003eNKX3-1\u003c/em\u003e, \u003cem\u003eUAP1\u003c/em\u003e, \u003cem\u003eABCC4\u003c/em\u003e, and \u003cem\u003eDHCR24\u003c/em\u003e). Across all tested genes we found that inhibiting those CREs, that had a dominant chromatin loop, significantly impacted androgen-induced transcription (\u003cstrong\u003eFig.\u0026nbsp;6A\u003c/strong\u003e). Importantly, as we observed highest dynamic change in contact frequency at ARBS3 and ARBS2 for KLK2 and KLK3, respectively (\u003cstrong\u003eFig.\u0026nbsp;5E\u003c/strong\u003e), the highest gene expression inhibition is observed at these ARBSs. Supporting the kinetics of the dominance model, we observed an inverse correlation between the gene expression inhibition and the dynamic change in contact frequency of loops during androgen stimulation (\u003cstrong\u003eFig.\u0026nbsp;6B\u003c/strong\u003e). This correlation was greater than other genomic features including AR, FOXA1, H3K4me3, H3K27ac and chromatin accessibility (\u003cstrong\u003eSupp Fig.\u0026nbsp;10\u003c/strong\u003e). These results demonstrate that not all CREs contribute equally to androgen stimulation and that their contact frequency to promoters correlates with their impact on gene expression. Overall, these results underscore the importance of spatial genome organization in transcriptional regulation and validate our proposed multi-enhancer dominance model.\u003c/p\u003e\n\u003c/div\u003e"},{"header":"DISCUSSION","content":"\u003cp\u003eTranscription factors bind to specific DNA sites and regulate gene expression through the recruitment of co-regulatory proteins that activate transcriptional machinery\u003csup\u003e70,71\u003c/sup\u003e. Yet despite extensive research, many questions remain about how this complex process occurs, particularly as there are multiple CREs that interact with each promoter. Using the ligand-activated AR as a model system, we characterized how transcription factor activation changes the epigenetics and chromatin looping. Similar to published studies, our work showed that the AR stabilizes/recruits FOXA1 and increases both H3K27ac and chromatin accessibility (\u003cstrong\u003eFig.\u0026nbsp;2A\u003c/strong\u003e)\u003csup\u003e2,5,7,72,73\u003c/sup\u003e. However, by characterizing a kinetic dataset, we showed that the change in chromatin accessibility occurs after both FOXA1/AR binding and H3K27ac post-translational modifications, suggesting that this is mediated by the recruitment of additional chromatin-remodeling proteins. Those enhancers that are not bound by AR do not exhibit these changes. However, these epigenetic changes do not solely drive gene expression, as we observed a consistent pattern in all AR-bound CREs, regardless of either the direction of expression (upregulated and downregulated), or timing of maximal nascent transcription (\u003cstrong\u003eFig.\u0026nbsp;2; Fig.\u0026nbsp;4B\u003c/strong\u003e). These observations suggest a sequential mechanism, independent of gene expression, in which AR activation recruits specific co-regulatory proteins that alter histone modification and chromatin accessibility.\u003c/p\u003e\n\u003cp\u003eThis work also characterized how AR binding affects genome organization. This is a controversial field, with earlier studies proposing that steroid hormone receptors significantly reorganize chromatin looping when activated\u003csup\u003e74\u003c/sup\u003e. However, recent work has suggested that gene expression may occur through already-existing interactions\u003csup\u003e23\u003c/sup\u003e. Our research found that androgen treatment does not cause rewiring of chromatin contact loops but instead increases the contact frequencies of previously established loops (\u003cstrong\u003eFig.\u0026nbsp;3C, D; Supp Fig.\u0026nbsp;5\u003c/strong\u003e). Interestingly, we observed that maximal chromatin looping happens either during or after the maximal nascent gene expression (\u003cstrong\u003eFig.\u0026nbsp;4C\u003c/strong\u003e). This suggests that increasing chromatin looping does not precede, but instead likely occurs simultaneously with gene transcription. Supporting this result, recent work observed that higher nascent RNA production is associated with a higher frequency of chromatin contacts\u003csup\u003e22\u003c/sup\u003e. Changes in the chromatin contact frequency have also been shown to be associated with differential gene expression\u003csup\u003e20,23\u003c/sup\u003e. Although several studies observed temporal changes in chromatin looping that occur before maximal RNA expression\u003csup\u003e21,23\u003c/sup\u003e, this distinction is likely due to the experimental methodology used, as RNA-seq primarily quantifies mature mRNA, whereas Start-seq captures only nascent mRNA. Highlighting the consistent pattern of epigenetic features of AR-bound enhancers (\u003cstrong\u003eFig.\u0026nbsp;2; Fig.\u0026nbsp;4B\u003c/strong\u003e), we can infer chromatin looping is an additional mechanism which regulates gene expression independently of AR binding. The importance of chromatin loop contact frequency is highlighted when we look at AR-downregulated genes, which show similar changes in epigenetic alterations and chromatin accessibility but not contact frequency (\u003cstrong\u003eFig.\u0026nbsp;2B; Fig.\u0026nbsp;3E\u003c/strong\u003e). This suggests that AR binding recruits additional factors that potentially increase the contact frequencies of pre-established loops between enhancers and their target gene promoters to regulate the gene expression.\u003c/p\u003e\n\u003cp\u003eNumerous studies demonstrate that multiple enhancers contribute to the expression of a single gene\u003csup\u003e7,75\u003c/sup\u003e. However, there is no consensus about how each CRE contributes to gene expression. Our work suggests that connected enhancers contribute unevenly, and there exists dominant loops that have the largest impact on gene expression. These findings align with the assumptions made in the activity-by-contact (ABC) model\u003csup\u003e76\u003c/sup\u003e, which presumes that the enhancer\u0026rsquo;s impact on gene expression is correlated with the strength of the contact between them. Both our validation (\u003cstrong\u003eFig.\u0026nbsp;6\u003c/strong\u003e), and a recent large-scale CRISPRi study from Barshard \u003cem\u003eet al.\u003c/em\u003e\u003csup\u003e22\u003c/sup\u003e, demonstrate that those enhancers with higher contact frequency to target promoters are more likely to be functionally important which suggest a \u0026ldquo;dominance\u0026rdquo; model (\u003cstrong\u003eFig.\u0026nbsp;5D\u003c/strong\u003e). However, further improvements of this model can help us to understand the effect of individual CREs, thus allowing us to evaluate how multiple transcription factors impact gene expression.\u003c/p\u003e\n\u003cp\u003eGiven the complex nature of this system, we had to make several assumptions. First, we chose to define individual regulatory units based on chromatin accessibility, since defining enhancers and promoters by histone modifications is prone to false positives\u003csup\u003e77,78\u003c/sup\u003e. Within these CREs, we focused on hallmark androgen response genes (\u003cstrong\u003eFig.\u0026nbsp;1E\u003c/strong\u003e), as these have been extensively demonstrated to be regulated by AR. Next, we used HiChIP, a protein-centric HiC method, rather than conventional HiC to provide enhanced resolution and specificity in capturing protein-bound chromatin\u003csup\u003e79\u003c/sup\u003e. By characterizing both promoter-centric (H3K4me3) and enhancer-centric (H3K27ac) chromatin loops, we believe this provided us with different genomic perspectives of chromatin loops and reduced potential biases (\u003cstrong\u003eFig.\u0026nbsp;1B, C\u003c/strong\u003e)\u003csup\u003e21,80,81\u003c/sup\u003e. It is important to note that while H3K27ac is strongly impacted by AR binding we observed that H3K4me3 was relatively static (\u003cstrong\u003eFig.\u0026nbsp;2; Fig.\u0026nbsp;4B\u003c/strong\u003e), suggesting that the change in contact frequency (\u003cstrong\u003eFig.\u0026nbsp;3C-E\u003c/strong\u003e; \u003cstrong\u003eFig.\u0026nbsp;4C\u003c/strong\u003e) following androgen treatment was not due to capture efficiency. Finally, as gene expression regulation circuits are challenging to integrate due to the intricate network structures formed by diverse CREs (\u003cstrong\u003eFig.\u0026nbsp;1D\u003c/strong\u003e), we utilized regulatory networks wherein the nodes and edges represent the CREs and chromatin loops, respectively. Several studies have employed graph-based approaches to connect genomic regions and address various high-dimensional biological inquiries\u003csup\u003e82\u0026ndash;84\u003c/sup\u003e. The versatility of this approach underscores the quantitative advantages of utilizing graphs to characterize chromatin loops. Despite these limitations, this study represents one of the largest experimental datasets (\u003cstrong\u003eFig.\u0026nbsp;1A\u003c/strong\u003e) to characterize AR-mediated transcription.\u003c/p\u003e\n\u003cp\u003eOverall, this paper provides new insight into several important aspects of AR-mediated gene expression. We show that AR binding triggers a temporal cascade which increases FOXA1 and H3K27ac that affects chromatin accessibility. Further, we demonstrate that AR does not introduce novel chromatin loops, but instead increases the contact frequency between AR-bound enhancers and their target promoters. However, the effect of each enhancer on gene expression is markedly heterogeneous and proportional to promoter contact frequency. These findings suggest that while AR binding to DNA induces a step-wise epigenetic alteration, the impact of bound enhancers is strongly dependent on the contact frequency of the established chromatin loops with the target promoter.\u003c/p\u003e"},{"header":"Declarations","content":"\u003cp\u003e\u003cstrong\u003eACKNOWLEDGMENTS\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eN.A.L. was supported by funding from TUBITAK (221Z116), W81XWH-21-1-0234 (DoD), and CIHR PJT-173331. M.L.F. was supported by the Claudia Adams Barr Program for Innovative Cancer Research, the Dana-Farber Cancer Institute Presidential Initiatives Fund, the H.L. Snyder Medical Research Foundation, the Cutler Family Fund for Prevention and Early Detection, the Donahue Family Fund, W81XWH-21-1-0339, W81XWH-22-1-0951 (DoD), NIH Awards R01CA251555, R01CA227237, R01CA262577, R01CA259058 and a Movember PCF Challenge Award.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAUTHOR CONTRIBUTIONS\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eConceptualization, M.L.F., N.A.L.; Methodology, U.B.A., J.S., C.G.; Validation, D.O., Formal analysis, U.B.A., C.G., G.M.N.; Investigation, J.S., D.O., S.R.G.; Resources, K.A.; Data curation, J.S., B.J.F., U.B.A.; Writing \u0026ndash; Original Draft, U.B.A.; Writing \u0026ndash; Review \u0026amp; Editing, J.S., C.G., D.O., B.J.F., G.M.N., S.R.G., K.A., F.H., M.F.L., N.A.L.; Visualization, U.B.A., N.A.L.; Supervision, K.A., F.H., M.F.L., N.A.L.; Funding Acquisition M.F.L., N.A.L.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eDECLARATION OF INTERESTS\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe authors declare no competing interests.\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\n\u003cli\u003eNelson, P. S. \u003cem\u003eet al.\u003c/em\u003e The program of androgen-responsive genes in neoplastic prostate epithelium. \u003cem\u003eProc. Natl. Acad. Sci. U. S. A.\u003c/em\u003e \u003cstrong\u003e99\u003c/strong\u003e, 11890\u0026ndash;11895 (2002).\u003c/li\u003e\n\u003cli\u003eDavey, R. A. \u0026amp; Grossmann, M. Androgen Receptor Structure, Function and Biology: From Bench to Bedside. \u003cem\u003eClin. Biochem. Rev.\u003c/em\u003e \u003cstrong\u003e37\u003c/strong\u003e, 3\u0026ndash;15 (2016).\u003c/li\u003e\n\u003cli\u003eGeorget, V., T\u0026eacute;rouanne, B., Nicolas, J.-C. \u0026amp; Sultan, C. Mechanism of antiandrogen action: key role of hsp90 in conformational change and transcriptional activity of the androgen receptor. \u003cem\u003eBiochemistry\u003c/em\u003e \u003cstrong\u003e41\u003c/strong\u003e, 11824\u0026ndash;11831 (2002).\u003c/li\u003e\n\u003cli\u003eOzanne, D. M. \u003cem\u003eet al.\u003c/em\u003e Androgen receptor nuclear translocation is facilitated by the f-actin cross-linking protein filamin. \u003cem\u003eMol. Endocrinol.\u003c/em\u003e \u003cstrong\u003e14\u003c/strong\u003e, 1618\u0026ndash;1626 (2000).\u003c/li\u003e\n\u003cli\u003eTeng, M., Zhou, S., Cai, C., Lupien, M. \u0026amp; He, H. H. Pioneer of prostate cancer: past, present and the future of FOXA1. \u003cem\u003eProtein Cell\u003c/em\u003e \u003cstrong\u003e12\u003c/strong\u003e, 29\u0026ndash;38 (2021).\u003c/li\u003e\n\u003cli\u003eSahu, B. \u003cem\u003eet al.\u003c/em\u003e Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer. \u003cem\u003eEMBO J.\u003c/em\u003e \u003cstrong\u003e30\u003c/strong\u003e, 3962\u0026ndash;3976 (2011).\u003c/li\u003e\n\u003cli\u003eStelloo, S., Bergman, A. M. \u0026amp; Zwart, W. Androgen receptor enhancer usage and the chromatin regulatory landscape in human prostate cancers. \u003cem\u003eEndocr. Relat. Cancer\u003c/em\u003e \u003cstrong\u003e26\u003c/strong\u003e, R267\u0026ndash;R285 (2019).\u003c/li\u003e\n\u003cli\u003eWilson, S., Qi, J. \u0026amp; Filipp, F. V. Refinement of the androgen response element based on ChIP-Seq in androgen-insensitive and androgen-responsive prostate cancer cell lines. \u003cem\u003eSci. Rep.\u003c/em\u003e \u003cstrong\u003e6\u003c/strong\u003e, 32611 (2016).\u003c/li\u003e\n\u003cli\u003eHeinlein, C. A. \u0026amp; Chang, C. Androgen receptor (AR) coregulators: an overview. \u003cem\u003eEndocr. Rev.\u003c/em\u003e \u003cstrong\u003e23\u003c/strong\u003e, 175\u0026ndash;200 (2002).\u003c/li\u003e\n\u003cli\u003eJin, H.-J., Kim, J. \u0026amp; Yu, J. Androgen receptor genomic regulation. \u003cem\u003eTransl. Androl. Urol.\u003c/em\u003e \u003cstrong\u003e2\u003c/strong\u003e, 157\u0026ndash;177 (2013).\u003c/li\u003e\n\u003cli\u003eKadauke, S. \u0026amp; Blobel, G. A. Chromatin loops in gene regulation. \u003cem\u003eBiochim. Biophys. Acta\u003c/em\u003e \u003cstrong\u003e1789\u003c/strong\u003e, 17\u0026ndash;25 (2009).\u003c/li\u003e\n\u003cli\u003eZhu, I., Song, W., Ovcharenko, I. \u0026amp; Landsman, D. A model of active transcription hubs that unifies the roles of active promoters and enhancers. \u003cem\u003eNucleic Acids Res.\u003c/em\u003e \u003cstrong\u003e49\u003c/strong\u003e, 4493\u0026ndash;4505 (2021).\u003c/li\u003e\n\u003cli\u003eSahu, B. \u003cem\u003eet al.\u003c/em\u003e Sequence determinants of human gene regulatory elements. \u003cem\u003eNat. Genet.\u003c/em\u003e \u003cstrong\u003e54\u003c/strong\u003e, 283\u0026ndash;294 (2022).\u003c/li\u003e\n\u003cli\u003eMorgan, M. A. J. \u0026amp; Shilatifard, A. Reevaluating the roles of histone-modifying enzymes and their associated chromatin modifications in transcriptional regulation. \u003cem\u003eNat. Genet.\u003c/em\u003e \u003cstrong\u003e52\u003c/strong\u003e, 1271\u0026ndash;1281 (2020).\u003c/li\u003e\n\u003cli\u003eTsompana, M. \u0026amp; Buck, M. J. Chromatin accessibility: a window into the genome. \u003cem\u003eEpigenetics Chromatin\u003c/em\u003e \u003cstrong\u003e7\u003c/strong\u003e, 33 (2014).\u003c/li\u003e\n\u003cli\u003eWang, H. \u003cem\u003eet al.\u003c/em\u003e H3K4me3 regulates RNA polymerase II promoter-proximal pause-release. \u003cem\u003eNature\u003c/em\u003e \u003cstrong\u003e615\u003c/strong\u003e, 339\u0026ndash;348 (2023).\u003c/li\u003e\n\u003cli\u003eTewari, A. K. \u003cem\u003eet al.\u003c/em\u003e Chromatin accessibility reveals insights into androgen receptor activation and transcriptional specificity. \u003cem\u003eGenome Biol.\u003c/em\u003e \u003cstrong\u003e13\u003c/strong\u003e, R88 (2012).\u003c/li\u003e\n\u003cli\u003eGuo, H. \u003cem\u003eet al.\u003c/em\u003e Androgen receptor and MYC equilibration centralizes on developmental super-enhancer. \u003cem\u003eNat. Commun.\u003c/em\u003e \u003cstrong\u003e12\u003c/strong\u003e, 7308 (2021).\u003c/li\u003e\n\u003cli\u003eSawada, T., Kanemoto, Y., Kurokawa, T. \u0026amp; Kato, S. The epigenetic function of androgen receptor in prostate cancer progression. \u003cem\u003eFront Cell Dev Biol\u003c/em\u003e \u003cstrong\u003e11\u003c/strong\u003e, 1083486 (2023).\u003c/li\u003e\n\u003cli\u003eGreenwald, W. W. \u003cem\u003eet al.\u003c/em\u003e Subtle changes in chromatin loop contact propensity are associated with differential gene regulation and expression. \u003cem\u003eNat. Commun.\u003c/em\u003e \u003cstrong\u003e10\u003c/strong\u003e, 1054 (2019).\u003c/li\u003e\n\u003cli\u003eReed, K. S. M. \u003cem\u003eet al.\u003c/em\u003e Temporal analysis suggests a reciprocal relationship between 3D chromatin structure and transcription. \u003cem\u003eCell Rep.\u003c/em\u003e \u003cstrong\u003e41\u003c/strong\u003e, 111567 (2022).\u003c/li\u003e\n\u003cli\u003eBarshad, G. \u003cem\u003eet al.\u003c/em\u003e RNA polymerase II dynamics shape enhancer\u0026ndash;promoter interactions. \u003cem\u003eNat. Genet.\u003c/em\u003e \u003cstrong\u003e55\u003c/strong\u003e, 1370\u0026ndash;1380 (2023).\u003c/li\u003e\n\u003cli\u003eD\u0026rsquo;Ippolito, A. M. \u003cem\u003eet al.\u003c/em\u003e Pre-established Chromatin Interactions Mediate the Genomic Response to Glucocorticoids. \u003cem\u003eCell Syst\u003c/em\u003e \u003cstrong\u003e7\u003c/strong\u003e, 146-160.e7 (2018).\u003c/li\u003e\n\u003cli\u003eStelloo, S. \u003cem\u003eet al.\u003c/em\u003e Androgen receptor profiling predicts prostate cancer outcome. \u003cem\u003eEMBO Mol. Med.\u003c/em\u003e \u003cstrong\u003e7\u003c/strong\u003e, 1450\u0026ndash;1464 (2015).\u003c/li\u003e\n\u003cli\u003ePomerantz, M. M. \u003cem\u003eet al.\u003c/em\u003e The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis. \u003cem\u003eNat. Genet.\u003c/em\u003e \u003cstrong\u003e47\u003c/strong\u003e, 1346\u0026ndash;1351 (2015).\u003c/li\u003e\n\u003cli\u003ePomerantz, M. M. \u003cem\u003eet al.\u003c/em\u003e Prostate cancer reactivates developmental epigenomic programs during metastatic progression. \u003cem\u003eNat. Genet.\u003c/em\u003e \u003cstrong\u003e52\u003c/strong\u003e, 790\u0026ndash;799 (2020).\u003c/li\u003e\n\u003cli\u003eGrbesa, I. \u003cem\u003eet al.\u003c/em\u003e Reshaping of the androgen-driven chromatin landscape in normal prostate cells by early cancer drivers and effect on therapeutic sensitivity. \u003cem\u003eCell Rep.\u003c/em\u003e \u003cstrong\u003e36\u003c/strong\u003e, 109625 (2021).\u003c/li\u003e\n\u003cli\u003eHuang, C.-C. F. \u003cem\u003eet al.\u003c/em\u003e Functional mapping of androgen receptor enhancer activity. \u003cem\u003eGenome Biol.\u003c/em\u003e \u003cstrong\u003e22\u003c/strong\u003e, 149 (2021).\u003c/li\u003e\n\u003cli\u003eStaller, M. V. Transcription factors perform a 2-step search of the nucleus. \u003cem\u003eGenetics\u003c/em\u003e \u003cstrong\u003e222\u003c/strong\u003e, (2022).\u003c/li\u003e\n\u003cli\u003eUyehara, C. M. \u0026amp; Apostolou, E. 3D enhancer-promoter interactions and multi-connected hubs: Organizational principles and functional roles. \u003cem\u003eCell Rep.\u003c/em\u003e 112068 (2023).\u003c/li\u003e\n\u003cli\u003eCarey, M. The enhanceosome and transcriptional synergy. \u003cem\u003eCell\u003c/em\u003e \u003cstrong\u003e92\u003c/strong\u003e, 5\u0026ndash;8 (1998).\u003c/li\u003e\n\u003cli\u003eMerika, M. \u0026amp; Thanos, D. Enhanceosomes. \u003cem\u003eCurr. Opin. Genet. Dev.\u003c/em\u003e \u003cstrong\u003e11\u003c/strong\u003e, 205\u0026ndash;208 (2001).\u003c/li\u003e\n\u003cli\u003eChoi, J. \u003cem\u003eet al.\u003c/em\u003e Evidence for additive and synergistic action of mammalian enhancers during cell fate determination. \u003cem\u003eElife\u003c/em\u003e \u003cstrong\u003e10\u003c/strong\u003e, (2021).\u003c/li\u003e\n\u003cli\u003eAntosova, B. \u003cem\u003eet al.\u003c/em\u003e The Gene Regulatory Network of Lens Induction Is Wired through Meis-Dependent Shadow Enhancers of Pax6. \u003cem\u003ePLoS Genet.\u003c/em\u003e \u003cstrong\u003e12\u003c/strong\u003e, e1006441 (2016).\u003c/li\u003e\n\u003cli\u003eCannav\u0026ograve;, E. \u003cem\u003eet al.\u003c/em\u003e Shadow Enhancers Are Pervasive Features of Developmental Regulatory Networks. \u003cem\u003eCurr. Biol.\u003c/em\u003e \u003cstrong\u003e26\u003c/strong\u003e, 38\u0026ndash;51 (2016).\u003c/li\u003e\n\u003cli\u003eHong, J.-W., Hendrix, D. A. \u0026amp; Levine, M. S. Shadow enhancers as a source of evolutionary novelty. \u003cem\u003eScience\u003c/em\u003e \u003cstrong\u003e321\u003c/strong\u003e, 1314 (2008).\u003c/li\u003e\n\u003cli\u003eKvon, E. Z., Waymack, R., Gad, M. \u0026amp; Wunderlich, Z. Enhancer redundancy in development and disease. \u003cem\u003eNat. Rev. Genet.\u003c/em\u003e \u003cstrong\u003e22\u003c/strong\u003e, 324\u0026ndash;336 (2021).\u003c/li\u003e\n\u003cli\u003eBaca, S. C. \u003cem\u003eet al.\u003c/em\u003e Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer. \u003cem\u003eNat. Commun.\u003c/em\u003e \u003cstrong\u003e12\u003c/strong\u003e, 1979 (2021).\u003c/li\u003e\n\u003cli\u003eGiambartolomei, C. \u003cem\u003eet al.\u003c/em\u003e H3K27ac HiChIP in prostate cell lines identifies risk genes for prostate cancer susceptibility. \u003cem\u003eAm. J. Hum. Genet.\u003c/em\u003e \u003cstrong\u003e108\u003c/strong\u003e, 2284\u0026ndash;2300 (2021).\u003c/li\u003e\n\u003cli\u003eDorighi, K. M. \u003cem\u003eet al.\u003c/em\u003e Mll3 and Mll4 facilitate enhancer RNA synthesis and transcription from promoters independently of H3K4 monomethylation. \u003cem\u003eMol. Cell\u003c/em\u003e \u003cstrong\u003e66\u003c/strong\u003e, 568-576.e4 (2017).\u003c/li\u003e\n\u003cli\u003eHsu, J. Y. \u003cem\u003eet al.\u003c/em\u003e CRISPR-SURF: discovering regulatory elements by deconvolution of CRISPR tiling screen data. \u003cem\u003eNat. Methods\u003c/em\u003e \u003cstrong\u003e15\u003c/strong\u003e, 992\u0026ndash;993 (2018).\u003c/li\u003e\n\u003cli\u003eBae, S., Park, J. \u0026amp; Kim, J.-S. Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. \u003cem\u003eBioinformatics\u003c/em\u003e \u003cstrong\u003e30\u003c/strong\u003e, 1473\u0026ndash;1475 (2014).\u003c/li\u003e\n\u003cli\u003eDobin, A. \u003cem\u003eet al.\u003c/em\u003e STAR: ultrafast universal RNA-seq aligner. \u003cem\u003eBioinformatics\u003c/em\u003e \u003cstrong\u003e29\u003c/strong\u003e, 15\u0026ndash;21 (2013).\u003c/li\u003e\n\u003cli\u003ePatro, R., Duggal, G., Love, M. I., Irizarry, R. A. \u0026amp; Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. \u003cem\u003eNat. Methods\u003c/em\u003e \u003cstrong\u003e14\u003c/strong\u003e, 417\u0026ndash;419 (2017).\u003c/li\u003e\n\u003cli\u003eFrankish, A. \u003cem\u003eet al.\u003c/em\u003e GENCODE 2021. \u003cem\u003eNucleic Acids Res.\u003c/em\u003e \u003cstrong\u003e49\u003c/strong\u003e, D916\u0026ndash;D923 (2021).\u003c/li\u003e\n\u003cli\u003eCornwell, M. \u003cem\u003eet al.\u003c/em\u003e VIPER: Visualization Pipeline for RNA-seq, a Snakemake workflow for efficient and complete RNA-seq analysis. \u003cem\u003eBMC Bioinformatics\u003c/em\u003e \u003cstrong\u003e19\u003c/strong\u003e, 135 (2018).\u003c/li\u003e\n\u003cli\u003eQuinlan, A. R. \u0026amp; Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. \u003cem\u003eBioinformatics\u003c/em\u003e \u003cstrong\u003e26\u003c/strong\u003e, 841\u0026ndash;842 (2010).\u003c/li\u003e\n\u003cli\u003eQin, Q. \u003cem\u003eet al.\u003c/em\u003e ChiLin: a comprehensive ChIP-seq and DNase-seq quality control and analysis pipeline. \u003cem\u003eBMC Bioinformatics\u003c/em\u003e \u003cstrong\u003e17\u003c/strong\u003e, 404 (2016).\u003c/li\u003e\n\u003cli\u003eLi, H. \u0026amp; Durbin, R. Fast and accurate short read alignment with Burrows\u0026ndash;Wheeler transform. \u003cem\u003eBioinformatics\u003c/em\u003e \u003cstrong\u003e25\u003c/strong\u003e, 1754\u0026ndash;1760 (2009).\u003c/li\u003e\n\u003cli\u003eZhang, Y. \u003cem\u003eet al.\u003c/em\u003e Model-based analysis of ChIP-Seq (MACS). \u003cem\u003eGenome Biol.\u003c/em\u003e \u003cstrong\u003e9\u003c/strong\u003e, R137 (2008).\u003c/li\u003e\n\u003cli\u003eKent, W. J., Zweig, A. S., Barber, G., Hinrichs, A. S. \u0026amp; Karolchik, D. BigWig and BigBed: enabling browsing of large distributed datasets. \u003cem\u003eBioinformatics\u003c/em\u003e \u003cstrong\u003e26\u003c/strong\u003e, 2204\u0026ndash;2207 (2010).\u003c/li\u003e\n\u003cli\u003eServant, N. \u003cem\u003eet al.\u003c/em\u003e HiC-Pro: an optimized and flexible pipeline for Hi-C data processing. \u003cem\u003eGenome Biol.\u003c/em\u003e \u003cstrong\u003e16\u003c/strong\u003e, 259 (2015).\u003c/li\u003e\n\u003cli\u003eBhattacharyya, S., Chandra, V., Vijayanand, P. \u0026amp; Ay, F. Identification of significant chromatin contacts from HiChIP data by FitHiChIP. \u003cem\u003eNat. Commun.\u003c/em\u003e \u003cstrong\u003e10\u003c/strong\u003e, 4221 (2019).\u003c/li\u003e\n\u003cli\u003eSubramanian, A. \u003cem\u003eet al.\u003c/em\u003e Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. \u003cem\u003eProc. Natl. Acad. Sci. U. S. A.\u003c/em\u003e \u003cstrong\u003e102\u003c/strong\u003e, 15545\u0026ndash;15550 (2005).\u003c/li\u003e\n\u003cli\u003eYardımcı, G. G. \u003cem\u003eet al.\u003c/em\u003e Measuring the reproducibility and quality of Hi-C data. \u003cem\u003eGenome Biol.\u003c/em\u003e \u003cstrong\u003e20\u003c/strong\u003e, 1\u0026ndash;19 (2019).\u003c/li\u003e\n\u003cli\u003eHarmston, N., Ing-Simmons, E., Perry, M., Bare\u0026scaron;ić, A. \u0026amp; Lenhard, B. GenomicInteractions: An R/Bioconductor package for manipulating and investigating chromatin interaction data. \u003cem\u003eBMC Genomics\u003c/em\u003e \u003cstrong\u003e16\u003c/strong\u003e, 963 (2015).\u003c/li\u003e\n\u003cli\u003eHagberg, A., Swart, P. \u0026amp; S Chult, D. \u003cem\u003eExploring network structure, dynamics, and function using networkx\u003c/em\u003e. https://www.osti.gov/biblio/960616 (2008).\u003c/li\u003e\n\u003cli\u003eRobinson, M. D. \u0026amp; Oshlack, A. A scaling normalization method for differential expression analysis of RNA-seq data. \u003cem\u003eGenome Biol.\u003c/em\u003e \u003cstrong\u003e11\u003c/strong\u003e, R25 (2010).\u003c/li\u003e\n\u003cli\u003eBuitinck, L. \u003cem\u003eet al.\u003c/em\u003e API design for machine learning software: experiences from the scikit-learn project. \u003cem\u003earXiv [cs.LG]\u003c/em\u003e (2013).\u003c/li\u003e\n\u003cli\u003eBreiman, L. \u003cem\u003eMach. Learn.\u003c/em\u003e \u003cstrong\u003e45\u003c/strong\u003e, 5\u0026ndash;32 (2001).\u003c/li\u003e\n\u003cli\u003eHunter. Matplotlib: A 2D Graphics Environment. \u003cstrong\u003e9\u003c/strong\u003e, 90\u0026ndash;95 (2007).\u003c/li\u003e\n\u003cli\u003eVirtanen, P., Gommers, R., Oliphant, T. E. \u0026amp; Haberland, M. Fundamental algorithms for scientific computing in python and SciPy 1.0 contributors. SciPy 1.0. \u003cem\u003eNat. Methods\u003c/em\u003e.\u003c/li\u003e\n\u003cli\u003eLiang, G. \u003cem\u003eet al.\u003c/em\u003e Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome. \u003cem\u003eProc. Natl. Acad. Sci. U. S. A.\u003c/em\u003e \u003cstrong\u003e101\u003c/strong\u003e, 7357\u0026ndash;7362 (2004).\u003c/li\u003e\n\u003cli\u003eCreyghton, M. P. \u003cem\u003eet al.\u003c/em\u003e Histone H3K27ac separates active from poised enhancers and predicts developmental state. \u003cem\u003eProceedings of the National Academy of Sciences\u003c/em\u003e vol. 107 21931\u0026ndash;21936 Preprint at https://doi.org/10.1073/pnas.1016071107 (2010).\u003c/li\u003e\n\u003cli\u003eRoadmap Epigenomics Consortium \u003cem\u003eet al.\u003c/em\u003e Integrative analysis of 111 reference human epigenomes. \u003cem\u003eNature\u003c/em\u003e \u003cstrong\u003e518\u003c/strong\u003e, 317\u0026ndash;330 (2015).\u003c/li\u003e\n\u003cli\u003eChen, Z. \u003cem\u003eet al.\u003c/em\u003e Androgen Receptor-Activated Enhancers Simultaneously Regulate Oncogene TMPRSS2 and lncRNA PRCAT38 in Prostate Cancer. \u003cem\u003eCells\u003c/em\u003e \u003cstrong\u003e8\u003c/strong\u003e, (2019).\u003c/li\u003e\n\u003cli\u003eHenriques, T. \u003cem\u003eet al.\u003c/em\u003e Widespread transcriptional pausing and elongation control at enhancers. \u003cem\u003eGenes \u0026amp; Development\u003c/em\u003e vol. 32 26\u0026ndash;41 Preprint at https://doi.org/10.1101/gad.309351.117 (2018).\u003c/li\u003e\n\u003cli\u003eBreiman, L. Random Forests. \u003cem\u003eMach. Learn.\u003c/em\u003e \u003cstrong\u003e45\u003c/strong\u003e, 5\u0026ndash;32 (2001).\u003c/li\u003e\n\u003cli\u003eLawrence, M. G., Lai, J. \u0026amp; Clements, J. A. Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus. \u003cem\u003eEndocr. Rev.\u003c/em\u003e \u003cstrong\u003e31\u003c/strong\u003e, 407\u0026ndash;446 (2010).\u003c/li\u003e\n\u003cli\u003eRem\u0026eacute;nyi, A., Sch\u0026ouml;ler, H. R. \u0026amp; Wilmanns, M. Combinatorial control of gene expression. \u003cem\u003eNat. Struct. Mol. Biol.\u003c/em\u003e \u003cstrong\u003e11\u003c/strong\u003e, 812\u0026ndash;815 (2004).\u003c/li\u003e\n\u003cli\u003eSproul, D., Gilbert, N. \u0026amp; Bickmore, W. A. The role of chromatin structure in regulating the expression of clustered genes. \u003cem\u003eNat. Rev. Genet.\u003c/em\u003e \u003cstrong\u003e6\u003c/strong\u003e, 775\u0026ndash;781 (2005).\u003c/li\u003e\n\u003cli\u003eCosgrove, M. S., Boeke, J. D. \u0026amp; Wolberger, C. Regulated nucleosome mobility and the histone code. \u003cem\u003eNat. Struct. Mol. Biol.\u003c/em\u003e \u003cstrong\u003e11\u003c/strong\u003e, 1037\u0026ndash;1043 (2004).\u003c/li\u003e\n\u003cli\u003eGlont, S.-E., Chernukhin, I. \u0026amp; Carroll, J. S. Comprehensive Genomic Analysis Reveals that the Pioneering Function of FOXA1 Is Independent of Hormonal Signaling. \u003cem\u003eCell Rep.\u003c/em\u003e \u003cstrong\u003e26\u003c/strong\u003e, 2558-2565.e3 (2019).\u003c/li\u003e\n\u003cli\u003eLe Dily, F. \u0026amp; Beato, M. Signaling by Steroid Hormones in the 3D Nuclear Space. \u003cem\u003eInt. J. Mol. Sci.\u003c/em\u003e \u003cstrong\u003e19\u003c/strong\u003e, (2018).\u003c/li\u003e\n\u003cli\u003eKarnuta, J. M. \u0026amp; Scacheri, P. C. Enhancers: bridging the gap between gene control and human disease. \u003cem\u003eHum. Mol. Genet.\u003c/em\u003e \u003cstrong\u003e27\u003c/strong\u003e, R219\u0026ndash;R227 (2018).\u003c/li\u003e\n\u003cli\u003eFulco, C. P. \u003cem\u003eet al.\u003c/em\u003e Activity-by-contact model of enhancer-promoter regulation from thousands of CRISPR perturbations. \u003cem\u003eNat. Genet.\u003c/em\u003e \u003cstrong\u003e51\u003c/strong\u003e, 1664\u0026ndash;1669 (2019).\u003c/li\u003e\n\u003cli\u003eAndersson, R. \u0026amp; Sandelin, A. Determinants of enhancer and promoter activities of regulatory elements. \u003cem\u003eNat. Rev. Genet.\u003c/em\u003e \u003cstrong\u003e21\u003c/strong\u003e, 71\u0026ndash;87 (2020).\u003c/li\u003e\n\u003cli\u003eOudelaar, A. M. \u0026amp; Higgs, D. R. The relationship between genome structure and function. \u003cem\u003eNat. Rev. Genet.\u003c/em\u003e \u003cstrong\u003e22\u003c/strong\u003e, 154\u0026ndash;168 (2021).\u003c/li\u003e\n\u003cli\u003eMumbach, M. R. \u003cem\u003eet al.\u003c/em\u003e HiChIP: efficient and sensitive analysis of protein-directed genome architecture. \u003cem\u003eNat. Methods\u003c/em\u003e \u003cstrong\u003e13\u003c/strong\u003e, 919\u0026ndash;922 (2016).\u003c/li\u003e\n\u003cli\u003eMumbach, M. R. \u003cem\u003eet al.\u003c/em\u003e Enhancer connectome in primary human cells identifies target genes of disease-associated DNA elements. \u003cem\u003eNat. Genet.\u003c/em\u003e \u003cstrong\u003e49\u003c/strong\u003e, 1602\u0026ndash;1612 (2017).\u003c/li\u003e\n\u003cli\u003eCrispatzu, G. \u003cem\u003eet al.\u003c/em\u003e The chromatin, topological and regulatory properties of pluripotency-associated poised enhancers are conserved in vivo. \u003cem\u003eNat. Commun.\u003c/em\u003e \u003cstrong\u003e12\u003c/strong\u003e, 4344 (2021).\u003c/li\u003e\n\u003cli\u003eCao, Z.-J. \u0026amp; Gao, G. Multi-omics single-cell data integration and regulatory inference with graph-linked embedding. \u003cem\u003eNat. Biotechnol.\u003c/em\u003e (2022) doi:10.1038/s41587-022-01284-4.\u003c/li\u003e\n\u003cli\u003ePliner, H. A. \u003cem\u003eet al.\u003c/em\u003e Cicero Predicts cis-Regulatory DNA Interactions from Single-Cell Chromatin Accessibility Data. \u003cem\u003eMolecular Cell\u003c/em\u003e vol. 71 858-871.e8 Preprint at https://doi.org/10.1016/j.molcel.2018.06.044 (2018).\u003c/li\u003e\n\u003cli\u003eThibodeau, A., M\u0026aacute;rquez, E. J., Shin, D.-G., Vera-Licona, P. \u0026amp; Ucar, D. Chromatin interaction networks revealed unique connectivity patterns of broad H3K4me3 domains and super enhancers in 3D chromatin. \u003cem\u003eSci. Rep.\u003c/em\u003e \u003cstrong\u003e7\u003c/strong\u003e, 14466 (2017).\u003c/li\u003e\n\u003c/ol\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"
[email protected]","identity":"nature-portfolio","isNatureJournal":true,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"","title":"Nature Portfolio","twitterHandle":"","acdcEnabled":false,"dfaEnabled":false,"editorialSystem":"ejp","reportingPortfolio":"","inReviewEnabled":true,"inReviewRevisionsEnabled":false},"keywords":"Androgen receptor (AR), Transcription factor (TF), Cis-regulatory elements (CRE), 3D Genome organization, Gene expression regulation","lastPublishedDoi":"10.21203/rs.3.rs-3854707/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-3854707/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eAndrogen receptor (AR)-mediated transcription plays a critical role in normal prostate development and prostate cancer growth. AR drives gene expression by binding to thousands of cis-regulatory elements (CRE) that loop to hundreds of target promoters. With multiple CREs interacting with a single promoter, it remains unclear how individual AR bound CREs contribute to gene expression. To characterize the involvement of these CREs, we investigated the AR-driven epigenetic and chromosomal chromatin looping changes. We collected a kinetic multi-omic dataset comprised of steady-state mRNA, chromatin accessibility, transcription factor binding, histone modifications, chromatin looping, and nascent RNA. Using an integrated regulatory network, we found that AR binding induces sequential changes in the epigenetic features at CREs, independent of gene expression. Further, we showed that binding of AR does not result in a substantial rewiring of chromatin loops, but instead increases the contact frequency of pre-existing loops to target promoters. Our results show that gene expression strongly correlates to the changes in contact frequency. We then proposed and experimentally validated an unbalanced multi-enhancer model where the impact on gene expression of AR-bound enhancers is heterogeneous, and is proportional to their contact frequency with target gene promoters. Overall, these findings provide new insight into AR-mediated gene expression upon acute androgen simulation and develop a mechanistic framework to investigate nuclear receptor mediated perturbations.\u003c/p\u003e","manuscriptTitle":"Decoding the Epigenetics and Chromatin Loop Dynamics of Androgen Receptor-Mediated Transcription","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2024-02-02 15:35:37","doi":"10.21203/rs.3.rs-3854707/v1","editorialEvents":[],"status":"published","journal":{"display":true,"email":"
[email protected]","identity":"nature-communications","isNatureJournal":true,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"NCOMMS","sideBox":"Learn more about [Nature Communications](http://www.nature.com/ncomms/)","snPcode":"","submissionUrl":"https://mts-ncomms.nature.com/","title":"Nature Communications","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"ejp","reportingPortfolio":"Nature Communications","inReviewEnabled":true,"inReviewRevisionsEnabled":false}}],"origin":"","ownerIdentity":"5cbd996f-a602-4df9-baa7-4a53b662fae4","owner":[],"postedDate":"February 2nd, 2024","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"published-in-journal","subjectAreas":[{"id":28400345,"name":"Biological sciences/Molecular biology/Transcription/Transcriptional regulatory elements"},{"id":28400346,"name":"Biological sciences/Molecular biology/Chromatin/Chromatin structure"},{"id":28400347,"name":"Biological sciences/Computational biology and bioinformatics/Databases"},{"id":28400348,"name":"Biological sciences/Genetics/Epigenomics"}],"tags":[],"updatedAt":"2024-11-03T08:06:34+00:00","versionOfRecord":{"articleIdentity":"rs-3854707","link":"https://doi.org/10.1038/s41467-024-53758-5","journal":{"identity":"nature-communications","isVorOnly":false,"title":"Nature Communications"},"publishedOn":"2024-11-03 04:00:00","publishedOnDateReadable":"November 3rd, 2024"},"versionCreatedAt":"2024-02-02 15:35:37","video":"","vorDoi":"10.1038/s41467-024-53758-5","vorDoiUrl":"https://doi.org/10.1038/s41467-024-53758-5","workflowStages":[]},"version":"v1","identity":"rs-3854707","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-3854707","identity":"rs-3854707","version":["v1"]},"buildId":"qtupq5eGEP_6zYnWcrvyt","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.